View Filing Data

Print Document View Excel Document

Document And Entity Information - USD ($)	12 Months Ended
Document And Entity Information - USD ($)	Dec. 31, 2014	Feb. 17, 2015	Jun. 30, 2014
Document and Entity Information [Abstract]
Entity Registrant Name	TEXAS INSTRUMENTS INC
Entity Central Index Key	0000097476
Current Fiscal Year End Date	--12-31
Entity Filer Category	Large Accelerated Filer
Document Type	10-K
Document Period End Date	Dec. 31, 2014
Document Fiscal Year Focus	2014
Document Fiscal Period Focus	FY
Amendment Flag	false
Entity Common Stock, Shares Outstanding		1,047,142,301
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Public Float			$ 50,978,062,488

Consolidated Statements of Income - USD ($) shares in Millions, $ in Millions	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Income Statement [Abstract]
Revenue	$ 13,045	$ 12,205	$ 12,825
Cost of revenue (COR)	5,618	5,841	6,457
Gross profit	7,427	6,364	6,368
Research and development (R&D)	1,358	1,522	1,877
Selling, general and administrative (SG&A)	1,843	1,858	1,804
Acquisition charges	330	341	450
Restructuring charges/other	(51)	(189)	264
Operating profit	3,947	2,832	1,973
Other income (expense), net (OI&E)	21	17	47
Interest and debt expense	94	95	85
Income before income taxes	3,874	2,754	1,935
Provision for income taxes	1,053	592	176
Net income	$ 2,821	$ 2,162	$ 1,759
Earnings per common share (EPS):
Basic (in dollars per share)	$ 2.61	$ 1.94	$ 1.53
Diluted (in dollars per share)	$ 2.57	$ 1.91	$ 1.51
Average shares outstanding (millions):
Basic (in shares)	1,065	1,098	1,132
Diluted (in shares)	1,080	1,113	1,146
Cash dividends declared per common share	$ 1.24	$ 1.07	$ 0.72
Income allocated to RSUs	$ (43)	$ (36)	$ (31)
Income allocated to common stock for diluted EPS	$ 2,778	$ 2,126	$ 1,728

Consolidated Statements of Comprehensive Income - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Statement of Comprehensive Income [Abstract]
Net income	$ 2,821	$ 2,162	$ 1,759
Net actuarial gains (losses) of defined benefit plans:
Adjustment, net of tax benefit (expense) of $25, ($60) and $29	(46)	105	(81)
Recognized within Net income, net of tax benefit (expense) of ($21), ($37) and ($104)	42	71	160
Prior service cost of defined benefit plans:
Adjustment, net of tax benefit (expense) of $0, $1 and $1	(1)	(3)	(2)
Recognized within Net income, net of tax benefit (expense) of $0, $2 and $0	0	(3)	0
Derivative instruments:
Change in fair value, net of tax benefit (expense) of $0, $0 and $1	0	0	(3)
Recognized within Net income, net of tax benefit (expense) of ($1), ($1) and $0	1	1	0
Available-for-sale investments:
Unrealized gains (losses), net of tax benefit (expense) of $0, $0 and ($1)	0	0	3
Other comprehensive income (loss), net of taxes	(4)	171	77
Total comprehensive income	$ 2,817	$ 2,333	$ 1,836

Consolidated Statements of Comprehensive Income (Parenthetical) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Net actuarial gains (losses) of defined benefit plans:
Adjustment, net of tax benefit (expense)	$ 25	$ (60)	$ 29
Recognized within Net income, net of tax benefit (expense)	(21)	(37)	(104)
Prior service cost of defined benefit plans:
Adjustment, net of tax benefit (expense)	0	1	1
Recognized within Net income, net of tax benefit (expense)	0	2	0
Derivative instruments:
Change in fair value, net of tax benefit (expense)	0	0	1
Recognized within Net income, net of tax benefit (expense)	(1)	(1)	0
Available-for-sale investments:
Unrealized gains (losses), net of tax benefit (expense)	$ 0	$ 0	$ (1)

Consolidated Balance Sheets - USD ($) $ in Millions	Dec. 31, 2014	Dec. 31, 2013
Current assets:
Cash and cash equivalents	$ 1,199	$ 1,627
Short-term investments	2,342	2,202
Accounts receivable, net of allowances of ($12) and ($22)	1,246	1,203
Raw materials	101	102
Work in process	896	919
Finished goods	787	710
Inventories	1,784	1,731
Deferred income taxes	347	393
Prepaid expenses and other current assets	850	863
Total current assets	7,768	8,019
Property, plant and equipment at cost	6,266	6,556
Accumulated depreciation	(3,426)	(3,157)
Property, plant and equipment, net	2,840	3,399
Long-term investments	224	216
Goodwill, net	4,362	4,362
Acquisition-related intangibles, net	1,902	2,223
Deferred income taxes	172	207
Capitalized software licenses, net	83	118
Overfunded retirement plans	127	130
Other assets	244	264
Total assets	17,722	18,938
Current liabilities:
Current portion of long-term debt	1,001	1,000
Accounts payable	437	422
Accrued compensation	651	554
Income taxes payable	71	119
Deferred income taxes	4	1
Accrued expenses and other liabilities	498	651
Total current liabilities	2,662	2,747
Long-term debt	3,641	4,158
Underfunded retirement plans	225	216
Deferred income taxes	399	548
Deferred credits and other liabilities	405	462
Total liabilities	7,332	8,131
Stockholders’ equity:
Preferred stock, $25 par value. Authorized – 10,000,000 shares. Participating cumulative preferred. None issued.	0	0
Common stock, $1 par value. Authorized – 2,400,000,000 shares. Shares issued – 1,740,815,939	1,741	1,741
Paid-in capital	1,368	1,211
Retained earnings	29,653	28,173
Treasury common stock at cost. Shares: 2014 – 694,189,127; 2013 – 658,012,970	(21,840)	(19,790)
Accumulated other comprehensive income (loss), net of taxes (AOCI)	(532)	(528)
Total stockholders’ equity	10,390	10,807
Total liabilities and stockholders’ equity	$ 17,722	$ 18,938

Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Millions	Dec. 31, 2014	Dec. 31, 2013
Current assets:
Allowance for doubtful accounts receivable, current	$ (12)	$ (22)
Stockholders’ equity:
Preferred stock, par value (in dollars per share)	$ 25	$ 25
Preferred stock, shares authorized (in shares)	10,000,000	10,000,000
Preferred stock, shares issued (in shares)	0	0
Common stock, par value (in dollars per share)	$ 1	$ 1
Common stock, shares authorized (in shares)	2,400,000,000	2,400,000,000
Common stock, shares issued (in shares)	1,740,815,939	1,740,815,939
Treasury stock (in shares)	694,189,127	658,012,970

Consolidated Statements of Cash Flows - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Cash flows from operating activities
Net income	$ 2,821	$ 2,162	$ 1,759
Adjustments to Net income:
Depreciation	850	879	957
Amortization of acquisition-related intangibles	321	336	342
Amortization of capitalized software	59	82	102
Stock-based compensation	277	287	263
Gains on sales of assets	(73)	(6)	0
Deferred income taxes	(61)	50	130
Gain on transfer of Japan substitutional pension	0	0	(144)
Increase (decrease) from changes in:
Accounts receivable	(49)	16	311
Inventories	(53)	26	5
Prepaid expenses and other current assets	65	(136)	162
Accounts payable and accrued expenses	(194)	(284)	99
Accrued compensation	89	18	(82)
Income taxes payable	(81)	78	(229)
Changes in funded status of retirement plans	(58)	28	(198)
Other	(21)	(152)	(63)
Cash flows from operating activities	3,892	3,384	3,414
Cash flows from investing activities
Capital expenditures	(385)	(412)	(495)
Proceeds from asset sales	142	21	0
Purchases of short-term investments	(3,107)	(3,907)	(2,802)
Proceeds from short-term investments	2,966	4,249	2,198
Other	7	46	60
Cash flows from investing activities	(377)	(3)	(1,039)
Cash flows from financing activities
Proceeds from issuance of long-term debt	498	986	1,492
Repayment of debt and commercial paper borrowings	(1,000)	(1,500)	(1,375)
Dividends paid	(1,323)	(1,175)	(819)
Stock repurchases	(2,831)	(2,868)	(1,800)
Proceeds from common stock transactions	616	1,314	523
Excess tax benefit from share-based payments	100	80	38
Other	(3)	(7)	(10)
Cash flows from financing activities	(3,943)	(3,170)	(1,951)
Net change in Cash and cash equivalents	(428)	211	424
Cash and cash equivalents at beginning of period	1,627	1,416	992
Cash and cash equivalents at end of period	$ 1,199	$ 1,627	$ 1,416

Consolidated Statements of Stockholders' Equity - USD ($) $ in Millions	Total	Common Stock	Paid-in Capital	Retained Earnings	Treasury Common Stock	AOCI
Balance at Dec. 31, 2011		$ 1,741	$ 1,194	$ 26,278	$ (17,485)	$ (776)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	$ 1,759	0	0	1,759	0	0
Dividends declared and paid		0	0	(819)	0	0
Common stock issued for stock-based awards		0	(337)	0	823	0
Stock repurchases		0	0	0	(1,800)	0
Stock-based compensation		0	263	0	0	0
Tax impact from exercise of options	133	0	56	0	0	0
Other comprehensive income (loss), net of taxes	77	0	0	0	0	77
Dividend equivalents paid on restricted stock units		0	0	(13)	0	0
Balance at Dec. 31, 2012		1,741	1,176	27,205	(18,462)	(699)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	2,162	0	0	2,162	0	0
Dividends declared and paid		0	0	(1,175)	0	0
Common stock issued for stock-based awards		0	(273)	0	1,540	0
Stock repurchases		0	0	0	(2,868)	0
Stock-based compensation		0	287	0	0	0
Tax impact from exercise of options	227	0	25	0	0	0
Other comprehensive income (loss), net of taxes	171	0	0	0	0	171
Dividend equivalents paid on restricted stock units		0	0	(19)	0	0
Other		0	(4)	0	0	0
Balance at Dec. 31, 2013		1,741	1,211	28,173	(19,790)	(528)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	2,821	0	0	2,821	0	0
Dividends declared and paid		0	0	(1,323)	0	0
Common stock issued for stock-based awards		0	(226)	0	781	0
Stock repurchases		0	0	0	(2,831)	0
Stock-based compensation		0	277	0	0	0
Tax impact from exercise of options	218	0	110	0	0	0
Other comprehensive income (loss), net of taxes	$ (4)	0	0	0	0	(4)
Dividend equivalents paid on restricted stock units		0	0	(18)	0	0
Other		0	(4)	0	0	0
Balance at Dec. 31, 2014		$ 1,741	$ 1,368	$ 29,653	$ (21,840)	$ (532)

Consolidated Statements of Stockholders' Equity (Parenthetical) - $ / shares	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Statement of Stockholders' Equity [Abstract]
Dividends declared and paid (in dollars per share)	$ 1.24	$ 1.07	$ 0.72

Description of business, including segment and geographic area information

12 Months Ended

Dec. 31, 2014

Segment Reporting [Abstract]

Description of business, including segment and geographic area information

We design, make and sell semiconductors to electronics designers and manufacturers all over the world. We have two reportable segments, which are established along major categories of products as follows:


•	Analog – consists of the following product lines: High Volume Analog & Logic; Power Management; High Performance Analog; and Silicon Valley Analog, which consists primarily of products that we acquired through our purchase of National Semiconductor Corporation (National) in 2011.


•	Embedded Processing – consists of the following product lines: Processor, Microcontrollers and Connectivity.

We report the results of our remaining business activities in Other. Other includes operating segments that do not meet the quantitative thresholds for individually reportable segments and cannot be aggregated with other operating segments. Other includes DLP® products, custom application-specific integrated circuits, calculators, royalties, and products from our former Wireless segment, which was eliminated effective January 1, 2013.

We also include in Other items that are not used in evaluating the results of or in allocating resources to our segments. These include acquisition-related charges (see Note 3); restructuring charges (see Note 4); and certain corporate-level items, such as litigation expenses, environmental costs, insurance settlements, and gains and losses from other activities, including asset dispositions. We allocate the remainder of our expenses associated with corporate activities to our operating segments based on specific methodologies, such as percentage of operating expenses or headcount.

Our centralized manufacturing and support organizations, such as facilities, procurement and logistics, provide support to our operating segments, including those in Other. Costs incurred by these organizations, including depreciation, are charged to the segments on a per-unit basis. Consequently, depreciation expense is not an independently identifiable component within the segments’ results and, therefore, is not provided. The assets and liabilities associated with these organizations are included in Other.

With the exception of goodwill, we do not identify or allocate assets by operating segment, nor does the chief operating decision maker evaluate operating segments using discrete asset information. There was no significant intersegment revenue. The accounting policies of the segments are the same as those described below in the summary of significant accounting policies and practices.

Segment information



	For Years Ended December 31,
	2014		2013		2012
Revenue:
Analog	$	8,104	$	7,194	$	6,998
Embedded Processing	2,740		2,450		2,257
Other	2,201		2,561		3,570
Total revenue	$	13,045	$	12,205	$	12,825
Operating profit:
Analog	$	2,786	$	1,859	$	1,650
Embedded Processing	384		185		158
Other	777		788		165
Total operating profit	$	3,947	$	2,832	$	1,973

Geographic area information

The following geographic area information includes revenue, based on product shipment destination and royalty payor location, and property, plant and equipment, based on physical location:



	For Years Ended December 31,
	2014		2013		2012
Revenue:
United States	$	1,625	$	1,666	$	1,596
Asia (a)	7,915		7,370		7,808
Europe	2,293		1,926		1,861
Japan	1,032		1,072		1,357
Rest of world	180		171		203
Total revenue	$	13,045	$	12,205	$	12,825

(a) Revenue from products shipped into China, including Hong Kong, was $5.7 billion in 2014, $5.2 billion in 2013 and $5.4 billion in 2012.



	December 31,
	2014		2013		2012
Property, plant and equipment, net:
United States	$	1,436	$	1,765	$	1,931
Asia	1,096		1,277		1,547
Europe	162		196		241
Japan	124		144		174
Rest of world	22		17		19
Total property, plant and equipment, net	$	2,840	$	3,399	$	3,912

Basis of presentation and significant accounting policies and practices

12 Months Ended

Dec. 31, 2014

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Basis of presentation and significant accounting policies and practices

Basis of presentation

The consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (GAAP). The basis of these financial statements is comparable for all periods presented herein.

The consolidated financial statements include the accounts of all subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. All dollar amounts in the financial statements and tables in these notes, except per-share amounts, are stated in millions of U.S. dollars unless otherwise indicated. We have reclassified certain amounts in the prior periods’ financial statements to conform to the 2014 presentation. The preparation of financial statements requires the use of estimates from which final results may vary.

Significant accounting policies and practices

Revenue recognition

We recognize revenue from sales of our products, including direct sales to our distributors, when title and risk of loss pass, which usually occurs upon shipment or delivery to the customer or distributor, depending upon the terms of the sales order; when persuasive evidence of an arrangement exists; when sales amounts are fixed or determinable; and when collectability is reasonably assured. For sales to distributors, payment is due on our standard commercial terms and is not contingent upon resale of the products. In 2014, about 60 percent of our revenue was generated from sales of our products to distributors.

We recognize revenue net of allowances, which are management’s estimates of future credits to be granted to customers or distributors under programs common in the semiconductor industry. These allowances are based on analysis of historical data, current economic conditions, and contractual terms and are recorded when revenue is recognized. Allowances may include volume-based incentives, product returns due to quality issues, incentives designed to maximize growth opportunities and special pricing arrangements. For instance, we sell to distributors at standard published prices, but we may grant them price adjustment credits in response to individual competitive opportunities. To estimate allowances, we use statistical percentages of revenue, which are determined quarterly based upon recent historical adjustment trends. Historical claims data are maintained for each of the programs, with differences among geographic regions taken into consideration. We continually monitor the actual claimed allowances against our estimates, and we adjust our estimates as appropriate to reflect trends in distributor revenue and inventory levels. Allowances are also adjusted when recent historical data do not represent anticipated future activity.

We may also provide distributors an allowance to scrap certain slow-selling or obsolete products in their inventory, estimated as a negotiated fixed percentage of each distributor’s purchases from us. In addition, if we publish a new price for a product that is lower than that paid by distributors for the same product still remaining in each distributor’s on-hand inventory, we may credit them for the difference between those prices. The allowance for this type of credit is based on the identified product price difference applied to our estimate of each distributor’s on-hand inventory of that product.

We believe we can reasonably and reliably estimate allowances for credits to distributors in a timely manner.

Revenue from sales of our products that are subject to inventory consignment agreements, including consignment arrangements with distributors, is recognized in accordance with the principles discussed above, but delivery occurs when the customer or distributor pulls product from consignment inventory that we store at designated locations. About 60 percent of our distributor revenue is generated from sales of consigned inventory. The allowances we record against this revenue are not material.

We determine the amount and timing of royalty revenue based on our contractual agreements with intellectual property licensees. We recognize royalty revenue when earned under the terms of the agreements and when we consider realization of payment to be probable.

In addition, we record allowances for accounts receivable that we estimate may not be collected. We monitor collectability of accounts receivable primarily through review of the accounts receivable aging. When collection is at risk, we assess the impact on amounts recorded for bad debts and, if necessary, will record a charge in the period such determination is made.

We recognize shipping fees received from customers in revenue, and we include the shipping and handling costs in COR.

Advertising costs

We expense advertising and other promotional costs as incurred. This expense was $45 million in 2014, $46 million in 2013 and $46 million in 2012.

Restructuring charges

Restructuring charges may consist of voluntary or involuntary severance-related charges, asset-related charges and other costs due to exit activities. We recognize voluntary termination benefits when the employee accepts the offered benefit arrangement. We recognize involuntary severance-related charges depending on whether the termination benefits are provided under an ongoing benefit arrangement or under a one-time benefit arrangement. If the former, we recognize the charges once they are probable and the amounts are estimable. If the latter, we recognize the charges once the benefits have been communicated to employees.

Restructuring activities associated with assets are recorded as an adjustment to the basis of the asset, not as a liability. When we commit to a plan to abandon a long-lived asset before the end of its previously estimated useful life, we accelerate the recognition of depreciation to reflect the use of the asset over its shortened useful life. When an asset is held to be sold, we write down the carrying value to its net realizable value and cease depreciation. Restructuring actions may be viewed as an impairment indicator requiring testing of the recoverability of intangible assets, including goodwill.

Income taxes

We account for income taxes using an asset and liability approach. We record the amount of taxes payable or refundable for the current year and the deferred tax assets and liabilities for future tax consequences of events that have been recognized in the financial statements or tax returns. We record a valuation allowance when it is more likely than not that some or all of the deferred tax assets will not be realized.

Other assessed taxes

Some transactions require us to collect taxes such as sales, value-added and excise taxes from our customers. These transactions are presented in our Consolidated Statements of Income on a net (excluded from revenue) basis.

Earnings per share (EPS)

Unvested share-based payment awards that contain non-forfeitable rights to receive dividends or dividend equivalents, such as our restricted stock units (RSUs), are considered to be participating securities and the two-class method is used for purposes of calculating EPS. Under the two-class method, a portion of Net income is allocated to these participating securities and, therefore, is excluded from the calculation of EPS allocated to common stock, as shown in the table below.

Computation and reconciliation of earnings per common share are as follows (shares in millions):



	For Years Ended December 31,
	2014						2013						2012
	Net Income			Shares	EPS		Net Income			Shares	EPS		Net Income			Shares	EPS
Basic EPS:
Net income	$	2,821					$	2,162					$	1,759
Income allocated to RSUs	(44		)				(37		)				(31		)
Income allocated to common stock for basic EPS calculation	$	2,777		1,065	$	2.61	$	2,125		1,098	$	1.94	$	1,728		1,132	$	1.53

Adjustment for dilutive shares:
Stock-based compensation plans				15						15						14

Diluted EPS:
Net income	$	2,821					$	2,162					$	1,759
Income allocated to RSUs	(43		)				(36		)				(31		)
Income allocated to common stock for diluted EPS calculation	$	2,778		1,080	$	2.57	$	2,126		1,113	$	1.91	$	1,728		1,146	$	1.51

Potentially dilutive securities representing 11 million and 52 million shares of common stock that were outstanding during 2014 and 2012, respectively, were excluded from the computation of diluted earnings per common share for these periods because their effect would have been anti-dilutive. There were no potentially dilutive securities to exclude from the computation of diluted earnings per common share during 2013.

Investments

We present investments on our Consolidated Balance Sheets as cash equivalents, short-term investments or long-term investments. Specific details are as follows:

•

Cash equivalents and short-term investments: We consider investments in debt securities with maturities of 90 days or less from the date of our investment to be cash equivalents. We consider investments in debt securities with maturities beyond 90 days from the date of our investment as being available for use in current operations and include them in short-term investments. The primary objectives of our cash equivalent and short-term investment activities are to preserve capital and maintain liquidity while generating appropriate returns.


•	Long-term investments: Long-term investments consist of mutual funds, venture capital funds and non-marketable equity securities.


•	Classification of investments: Depending on our reasons for holding the investment and our ownership percentage, we classify our investments as either available for sale, trading, equity method or cost method, which are more fully described in Note 9. We determine cost or amortized cost, as appropriate, on a specific identification basis.

Inventories

Inventories are stated at the lower of cost or estimated net realizable value. Cost is generally computed on a currently adjusted standard cost basis, which approximates cost on a first-in first-out basis. Standard cost is based on the normal utilization of installed factory capacity. Cost associated with underutilization of capacity is expensed as incurred. Inventory held at consignment locations is included in our finished goods inventory. Consigned inventory was $258 million and $202 million as of December 31, 2014 and 2013, respectively.

We review inventory quarterly for salability and obsolescence. A statistical allowance is provided for inventory considered unlikely to be sold. The statistical allowance is based on an analysis of historical disposal activity, historical customer shipments, as well as estimated future sales. A specific allowance for each material type will be carried if there is a significant event not captured by the statistical allowance. We write off inventory in the period in which disposal occurs.

Property, plant and equipment; acquisition-related intangibles and other capitalized costs

Property, plant and equipment are stated at cost and depreciated over their estimated useful lives using the straight-line method. Our cost basis includes certain assets acquired in business combinations that were initially recorded at fair value as of the date of acquisition. Leasehold improvements are amortized using the straight-line method over the shorter of the remaining lease term or the estimated useful lives of the improvements. We amortize acquisition-related intangibles on a straight-line basis over the estimated economic life of the assets. Capitalized software licenses generally are amortized on a straight-line basis over the term of the license. Fully depreciated or amortized assets are written off against accumulated depreciation or amortization.

Impairments of long-lived assets

We regularly review whether facts or circumstances exist that indicate the carrying values of property, plant and equipment or other long-lived assets, including intangible assets, are impaired. We assess the recoverability of assets by comparing the projected undiscounted net cash flows associated with those assets to their respective carrying amounts. Any impairment charge is based on the excess of the carrying amount over the fair value of those assets. Fair value is determined by available market valuations, if applicable, or by discounted cash flows.

Goodwill and indefinite-lived intangibles

Goodwill is not amortized but is reviewed for impairment annually or more frequently if certain impairment indicators arise. We perform our annual goodwill impairment test as of October 1 for our reporting units, which compares the fair value for each reporting unit to its associated carrying value, including goodwill. See Note 10 for additional information.

Foreign currency

The functional currency for our non-U.S. subsidiaries is the U.S. dollar. Accounts recorded in currencies other than the U.S. dollar are remeasured into the functional currency. Current assets (except inventories), deferred income taxes, other assets, current liabilities and long-term liabilities are remeasured at exchange rates in effect at the end of each reporting period. Property, plant and equipment with associated depreciation and inventories are valued at historic exchange rates. Revenue and expense accounts other than depreciation for each month are remeasured at the appropriate daily rate of exchange. Currency exchange gains and losses from remeasurement are credited or charged to OI&E.

Derivatives and hedging

We use derivative financial instruments to manage exposure to foreign exchange risk. These instruments are primarily forward foreign currency exchange contracts, which are used as economic hedges to reduce the earnings impact that exchange rate fluctuations may have on our non-U.S. dollar net balance sheet exposures. Gains and losses from changes in the fair value of these forward foreign currency exchange contracts are credited or charged to OI&E. We do not apply hedge accounting to our foreign currency derivative instruments.

In connection with the issuance of long-term debt, we use financial derivatives such as treasury rate lock agreements that are recognized in AOCI and amortized over the life of the related debt. The results of these derivative transactions have not been material.

We do not use derivatives for speculative or trading purposes.

Changes in accounting standards

In April 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2014-08, Presentation of Financial Statements (Topic 205) and Property, Plant, and Equipment (Topic 360): Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity. This standard raises the threshold at which a disposal qualifies as a discontinued operation. Under the new guidance, only a disposal representing a strategic shift in operations that has or will have a major effect on an entity’s operations and financial results, such as a disposal of a major geographic area or a major line of business, should be presented as discontinued operations. In addition, the new standard requires additional disclosures of both discontinued operations and certain other disposals that do not meet the revised definition of a discontinued operation. This standard is effective for annual and interim reporting periods beginning as of January 1, 2015. In the event that a future disposition meets the revised criteria, we expect that this standard will have an impact on the presentation of our financial statements, and we will provide the appropriate disclosures at that time.

In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers (Topic 606). This standard provides a single set of guidelines for revenue recognition to be used across all industries and requires additional disclosures. This standard is effective for annual and interim reporting periods beginning as of January 1, 2017. We are currently evaluating the potential impact of this standard on our financial position and results of operations.

In August 2014, the FASB issued ASU No. 2014-15, Presentation of Financial Statements - Going Concern (Subtopic 205-40), Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern. This standard sets forth management’s responsibility to evaluate, each reporting period, whether there is substantial doubt about an entity’s ability to continue as a going concern, and if so, to provide related footnote disclosures. The standard is effective for annual and interim reporting periods ending after December 15, 2016. We expect it will have no impact on our financial position and results of operations.

Acquisition charges

12 Months Ended

Dec. 31, 2014

Business Combinations [Abstract]

Acquisition charges

We incurred various costs as a result of the 2011 acquisition of National that are included in Other for segment reporting purposes, consistent with how management measures the performance of its segments. Total acquisition-related charges are detailed below:



	For Years Ended December 31,
	2014		2013		2012
Amortization of intangible assets	$	319	$	323	$	325
Stock-based compensation	11		11		17
Retention bonuses	—		7		57
Severance and other benefits	—		—		16
Transaction and other costs	—		—		35
As recorded in Acquisition charges	330		341		450
As recorded in COR	—		—		21
Total acquisition-related charges	$	330	$	341	$	471

Acquisition charges

The amount of recognized amortization of intangible assets resulting from the National acquisition is based on estimated useful lives. See Note 10 for additional information.

Stock-based compensation was recognized for the accelerated vesting of equity awards upon the termination of employees, with additional compensation being recognized over the applicable vesting period for the remaining grantees.

Retention bonuses reflect amounts paid to former National employees who fulfilled agreed-upon service period obligations and that were recognized ratably over the required service period.

Severance and other benefits costs were for former National employees who were terminated after the closing date. About 350 jobs were eliminated by the end of 2012 as a result of redundancies and cost efficiency measures. As of December 31, 2014, a total of $86 million in cumulative charges have been recognized, of which $84 million has been paid, including $41 million related to change of control provisions under existing employment agreements.

Transaction and other costs included various expenses incurred in connection with the National acquisition.

COR

In 2011, we discontinued using one of National’s distributors. We acquired the distributor’s inventory at fair value, resulting in an incremental charge of $21 million to COR upon sale of the inventory in 2012.

- Definition

The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=25497992&loc=d3e1497-128463

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=25497992&loc=d3e1490-128463

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=25497992&loc=d3e1392-128463

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e7008-128479

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=25497992&loc=d3e1486-128463

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=39739317&loc=d3e4845-128472

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=25497992&loc=d3e1500-128463

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=25497992&loc=d3e1524-128463

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e7000-128479

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 20
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=39739317&loc=d3e4922-128472

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 20
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=39739317&loc=d3e4934-128472

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 20
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=39739317&loc=d3e4926-128472

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=25497992&loc=d3e1383-128463

Reference 15: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e6996-128479

+ Details

Restructuring charges/other

12 Months Ended

Dec. 31, 2014

Restructuring and Related Activities [Abstract]

Restructuring charges/other

Restructuring charges/other is comprised of the following components:



	For Years Ended December 31,
	2014			2013			2012
Restructuring charges by action:
2013 actions
Severance and benefits cost (a)	$	16		$	49		$	—
Other exit costs	10			—			—
	26			49			—
Prior actions
Severance and benefits cost (a)	(6		)	36			251
Accelerated depreciation	1			11			21
Other exit costs (a)	(1		)	30			128
	(6		)	77			400
Total restructuring charges	20			126			400

Other:
Gains on sales of assets	(75		)	—			—
Gain on technology transfer	—			(315		)	—
Gain on transfer of Japan substitutional pension	—			—			(144		)
Other	4			—			8
Restructuring charges/other	$	(51	)	$	(189	)	$	264

(a) Includes changes in estimates.

Restructuring charges/other are recognized in Other for segment reporting purposes. Restructuring actions related to the acquisition of National are discussed in Note 3 and the associated costs are reflected in the Acquisition charges line of our Consolidated Statements of Income.

2013 actions

We announced in January 2014 cost-saving actions in Embedded Processing and in Japan to reduce expenses and focus our investments on markets with greater potential for sustainable growth and strong long-term returns. We expect the actions to be completed by mid-2015. Cost reductions include the elimination of about 1,100 jobs worldwide. Through December 31, 2014, we have recognized $75 million in cumulative restructuring charges, with no further material charges expected. As of December 31, 2014, $43 million has been paid to terminated employees for severance and benefits.

Prior actions

In 2012, we announced a restructuring of our Wireless business to reduce expenses and focus our investments on markets with greater potential for sustainable growth and strong long-term returns. This action was completed in 2013. We recognized $383 million in cumulative restructuring charges, including a $90 million impairment of goodwill. As of December 31, 2014, $247 million has been paid to terminated employees for severance and benefits.

Also in 2012, we announced closure of two older semiconductor manufacturing facilities in Houston, Texas, and Hiji, Japan. We recognized $200 million in cumulative restructuring charges related to these closures, completing both by the end of 2013. As of December 31, 2014, $103 million has been paid to terminated employees for severance and benefits.

As of December 31, 2014 and 2013, we carried immaterial liabilities related to actions commenced in 2008 and 2009. The related expense was recognized in periods prior to 2011.

The table below reflects the changes in accrued restructuring balances associated with these actions:



	2013 Actions						Prior Actions
	Severance and Benefits			Other Charges			Severance and Benefits			Other Charges			Total
Accrual at December 31, 2011	$	—		$	—		$	109		$	7		$	116
Restructuring charges (a)	—			—			251			149			400
Non-cash items (b)	—			—			3			(124		)	(121		)
Payments	—			—			(23		)	(23		)	(46		)
Remaining accrual at December 31, 2012	—			—			340			9			349

Restructuring charges (a)	49			—			36			41			126
Non-cash items (b)	—			—			(5		)	(17		)	(22		)
Payments	—			—			(266		)	(26		)	(292		)
Remaining accrual at December 31, 2013	49			—			105			7			161

Restructuring charges (a)	16			10			(6		)	—			20
Payments	(43		)	(1		)	(73		)	(7		)	(124		)
Remaining accrual at December 31, 2014	$	22		$	9		$	26		$	—		$	57

(a) Includes changes in estimates.

(b) Reflects charges for goodwill impairment, stock-based compensation, impacts of postretirement benefit plans and accelerated depreciation.

The accrual balances above are primarily reported as a component of either Accrued expenses and other liabilities or Deferred credits and other liabilities on our Consolidated Balance Sheets, depending on the expected timing of payment.

Other

Gains on sales of assets

We recognized $75 million of gains on sales of assets in 2014. This consisted of $30 million associated with the sale of our site in Nice, France; $28 million associated with the sales of real estate in Santa Clara, California; and $17 million of asset sales associated primarily with the closure of our Houston, Texas, and Hiji, Japan, manufacturing facilities.

Gain on technology transfer

During 2013, we recognized a gain of $315 million on the transfer of wireless connectivity technology to a customer. This technology was associated with the former Wireless business.

Gain on transfer of Japan substitutional pension

During 2012, we transferred the obligations and assets of the substitutional portion of our Japan pension plan to the government of Japan, resulting in a net gain of $144 million. See Note 11 for additional details.

Stock-based compensation

12 Months Ended

Dec. 31, 2014

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Stock-based compensation

We have stock options outstanding to participants under long-term incentive plans. We also have assumed stock options that were granted by companies that we later acquired. Unless the options are acquisition-related replacement options, the option price per share may not be less than 100 percent of the fair market value of our common stock on the date of the grant. Substantially all the options have a 10-year term and vest ratably over four years. Our options generally continue to vest after the option recipient retires.

We also have RSUs outstanding under long-term incentive plans. Each RSU represents the right to receive one share of TI common stock on the vesting date, which is generally four years after the date of grant. Upon vesting, the shares are issued without payment by the grantee. Beginning with 2013 grants, RSUs generally continue to vest after the recipient retires. Holders of most RSUs receive an annual cash payment equivalent to the dividends paid on our common stock.

We have options and RSUs outstanding to non-employee directors under director compensation plans. The plans generally provide for annual grants of stock options and RSUs, a one-time grant of RSUs to each new non-employee director and the issuance of TI common stock upon the distribution of stock units credited to deferred compensation accounts established for such directors.

We also have an employee stock purchase plan under which options are offered to all eligible employees in amounts based on a percentage of the employee’s compensation, subject to a cap. Under the plan, the option price per share is 85 percent of the fair market value on the exercise date, and options have a three-month term.

Total stock-based compensation expense recognized was as follows:



	For Years Ended December 31,
	2014		2013		2012
Stock-based compensation expense recognized in:
COR	$	48	$	49	$	48
R&D	62		67		71
SG&A	156		160		127
Acquisition charges	11		11		17
Total	$	277	$	287	$	263

These amounts include expenses related to non-qualified stock options, RSUs and stock options offered under our employee stock purchase plan and are net of expected forfeitures.

We issue awards of non-qualified stock options with graded vesting provisions (e.g., 25 percent per year for four years). Generally, we recognize the related compensation expense on a straight-line basis over the minimum service period required for vesting of the award, adjusting for expected forfeiture activity. Awards issued to employees who are retirement eligible or nearing retirement eligibility are expensed on an accelerated basis.

Our RSUs generally vest four years after the date of grant. We recognize the related compensation expense on a straight-line basis over the vesting period, adjusting for expected forfeiture activity. Beginning with 2013 grants, RSUs issued to employees who are retirement eligible or nearing retirement eligibility are expensed on an accelerated basis.

Fair-value methods and assumptions

We account for all awards granted under our various stock-based compensation plans at fair value. We estimate the fair values for non-qualified stock options using the Black-Scholes-Merton option-pricing model with the following weighted average assumptions.



	For Years Ended December 31,
	2014			2013			2012
Weighted average grant date fair value, per share	$	8.13		$	6.78		$	8.31
Weighted average assumptions used:
Expected volatility	22		%	26		%	30		%
Expected lives (in years)	7.3			7.4			7.1
Risk-free interest rates	2.45		%	1.43		%	1.40		%
Expected dividend yields	2.72		%	2.56		%	2.10		%

We determine expected volatility on all options granted using available implied volatility rates. We believe that market-based measures of implied volatility are currently the best available indicators of the expected volatility used in these estimates.

We determine expected lives of options based on the historical option exercise experience of our optionees using a rolling 10-year average. We believe the historical experience method is the best estimate of future exercise patterns currently available.

Risk-free interest rates are determined using the implied yield currently available for zero-coupon U.S. government issues with a remaining term equal to the expected life of the options.

Expected dividend yields are based on the annualized approved quarterly dividend rate and the current market price of our common stock at the time of grant. No assumption for a future dividend rate change is included unless there is an approved plan to change the dividend in the near term.

The fair value per share of RSUs is determined based on the closing price of our common stock on the date of grant.

Our employee stock purchase plan is a discount-purchase plan and consequently the Black-Scholes-Merton option-pricing model is not used to determine the fair value per share of these awards. The fair value per share under this plan equals the amount of the discount.

Long-term incentive and director compensation plans

Stock option and RSU transactions under our long-term incentive and director compensation plans during 2014 were as follows:



	Stock Options				RSUs
	Shares		Weighted Average Exercise Price per Share		Shares		Weighted Average Grant Date Fair Value per Share
Outstanding grants, December 31, 2013	64,930,540		$	28.98	20,892,022		$	29.94
Granted	14,053,185		44.11		3,184,237		44.71
Vested RSUs	—		—		(5,609,627	)	23.68
Forfeited and expired	(1,832,897	)	36.54		(1,162,817	)	33.22
Exercised	(19,503,382	)	27.75		—		—
Outstanding grants, December 31, 2014	57,647,446		32.84		17,303,815		34.47

The weighted average grant date fair value of RSUs granted during the years 2014, 2013 and 2012 was $44.71, $33.70 and $31.60 per share, respectively. For the years ended December 31, 2014, 2013 and 2012, the total grant date fair value of shares vested from RSU grants was $133 million, $98 million and $120 million, respectively.

Summarized information about stock options outstanding at December 31, 2014, is as follows:



		Stock Options Outstanding				Options Exercisable
Range of Exercise Price		Number Outstanding (Shares)	Weighted Average Remaining Contractual Life (Years)	Weighted Average Exercise Price per Share		Number Exercisable (Shares)	Weighted Average Exercise Price per Share
$	14.47 to 20.00	4,061,577	4.0	$	14.98	4,061,577	$	14.98
	20.01 to 30.00	11,270,125	3.7	25.47		11,250,200	25.46
	30.01 to 40.00	28,910,636	6.5	33.00		12,288,339	33.14
	40.01 to 50.00	13,399,020	9.1	44.10		1,750	42.66
	50.01 to 55.41	6,088	9.9	55.41		—	—
	14.47 to 55.41	57,647,446	6.4	32.84		27,601,866	27.34

During the years ended December 31, 2014, 2013 and 2012, the aggregate intrinsic value (i.e., the difference in the closing market price on the date of exercise and the exercise price paid by the optionee) of options exercised was $367 million, $427 million and $244 million, respectively.

Summarized information as of December 31, 2014, about outstanding stock options that are vested and expected to vest, as well as stock options that are currently exercisable, is as follows:



	Outstanding Stock Options (Fully Vested and Expected to Vest) (a)		Options Exercisable
Number of outstanding (shares)	56,328,323		27,601,866
Weighted average remaining contractual life (in years)	6.3		4.4
Weighted average exercise price per share	$	32.69	$	27.34
Intrinsic value (millions of dollars)	$	1,170	$	721

(a) Includes effects of expected forfeitures of approximately 1 million shares. Excluding the effects of expected forfeitures, the aggregate intrinsic value of stock options outstanding was $1,189 million.

As of December 31, 2014, the total future compensation cost related to equity awards not yet recognized in the Consolidated Statements of Income was $308 million, consisting of $113 million related to unvested stock options and $195 million related to unvested RSUs. The $308 million is expected to be recognized as follows: $168 million in 2015, $91 million in 2016, $44 million in 2017 and $5 million in 2018.

Director deferred compensation

Directors who retire or resign from the board may receive stock distributions for compensation they elected to defer. For these stock distributions, we issued treasury shares. Director deferred stock activity during 2014 was as follows:



	Director Deferred Stock (Shares)
Outstanding, December 31, 2013	129,264
New shares deferred	13,636
Issued	(7,178	)
Outstanding, December 31, 2014	135,722

Employee stock purchase plan

Options outstanding under the employee stock purchase plan at December 31, 2014, had an exercise price equal to 85 percent of the fair market value of TI common stock on the date of automatic exercise. The automatic exercise occurred on January 2, 2015, resulting in an exercise price of $45.46 per share. Of the total outstanding options, none were exercisable at year-end 2014.

Employee stock purchase plan transactions during 2014 were as follows:



	Employee Stock Purchase Plan (Shares)		Exercise Price
Outstanding grants, December 31, 2013	485,408		$	36.64
Granted	1,673,479		41.60
Exercised	(1,784,184	)	39.44
Outstanding grants, December 31, 2014	374,703		45.46

The weighted average grant date fair value of options granted under the employee stock purchase plans during the years 2014, 2013 and 2012 was $7.34, $5.71 and $4.52 per share, respectively. During the years ended December 31, 2014, 2013 and 2012, the total intrinsic value of options exercised under these plans was $12 million, $13 million and $13 million, respectively.

Effect on shares outstanding and treasury shares

Treasury shares were acquired in connection with the board-authorized stock repurchase program. As of December 31, 2014, $3.17 billion of stock repurchase authorizations remain, and no expiration date has been specified.

Our current practice is to issue shares of common stock from treasury shares upon exercise of stock options, distribution of director deferred compensation and vesting of RSUs. The table below reflects the changes in our treasury shares:



	Stock Options		RSUs		Treasury Shares
Balance, December 31, 2011					601,131,631
Repurchases					59,757,780
Shares used for:
Stock options/RSUs	(22,409,816	)	(4,182,928	)
Previously unissued common shares (a)	180,955		4,593
Stock applied to taxes	—		990,845
ESPP	(2,829,498	)	—
Director deferred stock	—		—		(6,592	)
Total issued	(25,058,359	)	(3,187,490	)	(28,245,849	)
Balance, December 31, 2012					632,636,970

Repurchases					77,564,013
Shares used for:
Stock options/RSUs	(45,507,711	)	(5,741,981	)
Stock applied to taxes	—		1,461,422
ESPP	(2,386,834	)	—
Director deferred stock	—		—		(12,909	)
Total issued	(47,894,545	)	(4,280,559	)	(52,175,104	)
Balance, December 31, 2013					658,012,970

Repurchases					61,665,209
Shares used for:
Stock options/RSUs	(19,503,382	)	(5,609,627	)
Stock applied to exercises or taxes	6,618		1,408,701
ESPP	(1,784,184	)	—
Director deferred stock	—		—		(7,178	)
Total issued	(21,280,948	)	(4,200,926	)	(25,481,874	)
Balance, December 31, 2014					694,189,127

(a) Beginning in 2013, only treasury shares were issued.

Shares available for future grants and reserved for issuance are summarized below:



	December 31, 2014
Shares	Long-Term Incentive and Director Compensation Plans		Employee Stock Purchase Plan		Total
Reserved for issuance (a)	121,127,656		39,565,038		160,692,694
Shares to be issued upon exercise of outstanding options and RSUs (a)	(75,086,983	)	(374,703	)	(75,461,686	)
Available for future grants	46,040,673		39,190,335		85,231,008

(a) Includes 135,722 shares credited to directors’ deferred stock accounts that settle in shares of TI common stock. These shares are not included as grants outstanding at December 31, 2014.

The effects on cash flows were as follows:



	For Years Ended December 31,
	2014		2013		2012
Proceeds from common stock transactions	$	616	$	1,314	$	523
Tax benefit realized from stock options exercised	218		227		133

Profit sharing plans	12 Months Ended
Profit sharing plans	Dec. 31, 2014
Profit sharing plans [Abstract]
Profit sharing plans	Profit sharing plans Profit sharing benefits are generally formulaic and determined by one or more subsidiary or company-wide financial metrics. We pay profit sharing benefits primarily under the company-wide TI Employee Profit Sharing Plan. This plan provides for profit sharing to be paid based solely on TI’s operating margin for the full calendar year. Under this plan, TI must achieve a minimum threshold of 10 percent operating margin before any profit sharing is paid. At 10 percent operating margin, profit sharing will be 2 percent of eligible payroll. The maximum amount of profit sharing available under the plan is 20 percent of eligible payroll, which is paid only if TI’s operating margin is at or above 35 percent for a full calendar year. We recognized $269 million, $161 million and $96 million of profit sharing expense under the TI Employee Profit Sharing Plan in 2014, 2013 and 2012, respectively.

Income taxes

12 Months Ended

Dec. 31, 2014

Income Tax Disclosure [Abstract]

Income taxes

Income before Income Taxes



	U.S.		Non-U.S.		Total
2014	$	2,684	$	1,190	$	3,874
2013	1,507		1,247		2,754
2012	319		1,616		1,935

Provision (Benefit) for Income Taxes



	U.S. Federal			Non-U.S.		U.S. State			Total
2014
Current	$	911		$	194	$	9		$	1,114
Deferred	(73		)	11		1			(61		)
Total	$	838		$	205	$	10		$	1,053

2013
Current	$	291		$	247	$	4		$	542
Deferred	17			33		—			50
Total	$	308		$	280	$	4		$	592

2012
Current	$	(108	)	$	156	$	(2	)	$	46
Deferred	65			65		—			130
Total	$	(43	)	$	221	$	(2	)	$	176

Principal reconciling items from income tax computed at the statutory federal rate follow:



	For Years Ended December 31,
	2014			2013			2012
Computed tax at statutory rate	$	1,356		$	964		$	677
Non-U.S. effective tax rates	(212		)	(156		)	(345		)
U.S. R&D tax credit	(59		)	(129		)	—
U.S. tax benefit for manufacturing	(51		)	(66		)	(158		)
Impact of changes to uncertain tax positions	3			(14		)	(88		)
Non-deductible expenses	6			13			42
Other	10			(20		)	48
Total provision for income taxes	$	1,053		$	592		$	176

The total provision for 2013 in the reconciliation above includes $79 million of discrete tax benefits primarily for the reinstatement of the U.S. R&D tax credit retroactive to 2012.

Included in the non-U.S. effective tax rates reconciling item are benefits from tax holidays of $44 million, $40 million and $51 million in 2014, 2013 and 2012, respectively. The tax benefits relate to our operations in Malaysia and the Philippines, and expire in 2018 and 2017, respectively. The terms of the Malaysia tax holiday are currently under governmental review as required for the end of the first five years of the holiday period. We do not expect any potential change in the holiday to have a material impact on the financial statements.

The total provision for 2012 includes $252 million of discrete tax benefits primarily for additional U.S. tax benefits for manufacturing related to the years 2000 through 2011 and, to a lesser extent, audit adjustments.

The primary components of deferred income tax assets and liabilities were as follows:



	December 31,
	2014			2013
Deferred income tax assets:
Deferred loss and tax credit carryforwards	$	289		$	345
Accrued expenses	248			265
Stock-based compensation	238			262
Inventories and related reserves	157			162
Retirement costs for defined benefit and retiree health care	96			101
Other	122			148
	1,150			1,283
Valuation allowance	(195		)	(219		)
	955			1,064
Deferred income tax liabilities:
Acquisition-related intangibles and fair-value adjustments	(688		)	(804		)
International earnings	(104		)	(121		)
Property, plant and equipment	(10		)	(57		)
Other	(37		)	(31		)
	(839		)	(1,013		)
Net deferred income tax asset	$	116		$	51

The deferred income tax assets and liabilities based on tax jurisdictions are presented on the Consolidated Balance Sheets as follows:



	December 31,
	2014			2013
Current deferred income tax assets	$	347		$	393
Noncurrent deferred income tax assets	172			207
Current deferred income tax liabilities	(4		)	(1		)
Noncurrent deferred income tax liabilities	(399		)	(548		)
Net deferred income tax asset	$	116		$	51

We make an ongoing assessment regarding the realization of U.S. and non-U.S. deferred tax assets. This assessment is based on our evaluation of relevant criteria, including the existence of deferred tax liabilities that can be used to absorb deferred tax assets, taxable income in prior carryback years and expectations for future taxable income. In 2014, we recognized a net decrease of $24 million in our valuation allowance, due to unutilized tax credits.

We have U.S. and non-U.S. tax loss carryforwards of approximately $108 million, none of which will expire before the year 2024.

A provision has been made for deferred taxes on undistributed earnings of non-U.S. subsidiaries to the extent that dividend payments from these subsidiaries are expected to result in additional tax liability. The remaining undistributed earnings of approximately $7.67 billion at December 31, 2014, have been indefinitely reinvested outside of the United States; therefore, no U.S. tax provision has been made for taxes due upon remittance of these earnings. The indefinitely reinvested earnings of our non-U.S. subsidiaries are primarily invested in working capital and property, plant and equipment. Determination of the amount of unrecognized deferred income tax liability is not practical because of the complexities associated with its hypothetical calculation.

Cash payments made for income taxes, net of refunds, were $1.104 billion, $569 million and $171 million for the years ended December 31, 2014, 2013 and 2012, respectively.

Uncertain tax positions

We operate in a number of tax jurisdictions, and our income tax returns are subject to examination by tax authorities in those jurisdictions who may challenge any item on these tax returns. Because the matters challenged by authorities are typically complex, their ultimate outcome is uncertain. Before any benefit can be recorded in the financial statements, we must determine that it is “more likely than not” that a tax position will be sustained by the appropriate tax authorities. We recognize accrued interest related to uncertain tax positions and penalties as components of OI&E.

The changes in the total amounts of uncertain tax positions are summarized as follows:



	2014			2013			2012
Balance, January 1	$	91		$	184		$	210
Additions based on tax positions related to the current year	10			7			12
Additions for tax positions of prior years	52			19			45
Reductions for tax positions of prior years	(9		)	(10		)	(92		)
Settlements with tax authorities	(36		)	(96		)	39
Expiration of the statute of limitations for assessing taxes	—			(13		)	(30		)
Balance, December 31	$	108		$	91		$	184

Interest income (expense) recognized in the year ended December 31	$	6		$	(10	)	$	32

Interest receivable (payable) as of December 31	$	—		$	(5	)	$	8

The liability for uncertain tax positions and interest payable are components of Deferred credits and other liabilities on our Consolidated Balance Sheets. Interest receivable is a component of Other assets on our Consolidated Balance Sheets.

The $108 million liability for uncertain tax positions as of December 31, 2014, is comprised of positions that, if recognized, would impact the tax rate. If these tax liabilities are ultimately realized, $56 million of existing deferred tax assets would also be realized, related to refunds from counterparty jurisdictions resulting from procedures for relief from double taxation. Regarding the $108 million liability:

•

About $76 million of the liability represents uncertain tax positions for tax years in jurisdictions in which audit assessments have not been made. Of this liability, $52 million relates to the cumulative effect of a tax depreciation-related method change. The balance of this liability is primarily related to transfer pricing issues for which procedures for relief from double taxation will mitigate the tax rate impact of any difference between the actual tax assessments and our estimates.

•

About $32 million of the liability represents audit assessments. Of the liability, $29 million is related to transfer pricing issues for which there are ongoing procedures for relief from double taxation. Settlement of the $29 million is subject to timely completion of the tax treaty processes and a significant portion of that liability may be settled within the next 12 months. Settlement will not have a significant tax rate impact, as the tax rates of the counterparty jurisdictions are similar.

All of the $91 million liability for uncertain tax positions as of December 31, 2013, is made up of positions that, if recognized, would impact the tax rate. If these tax liabilities are ultimately realized, $76 million of deferred tax assets would also be realized, primarily related to refunds from counterparty jurisdictions resulting from procedures for relief from double taxation.

As of December 31, 2014, the statute of limitations remains open for U.S. federal tax returns for 2010 and following years. Audit activities related to our U.S. federal tax returns through 2009 have been completed except for certain pending tax treaty procedures for relief from double taxation and the review of refunds claimed on amended returns for years prior to 2010. The procedures for relief from double taxation pertain to U.S. federal tax returns for the years 2004 through 2010.

In non-U.S. jurisdictions, the years open to audit represent the years still open under the statute of limitations. With respect to major jurisdictions outside the United States, our subsidiaries are no longer subject to income tax audits for years before 2007.

Financial instruments and risk concentration

12 Months Ended

Dec. 31, 2014

Risks and Uncertainties [Abstract]

Financial instruments and risk concentration

Financial instruments

We hold derivative financial instruments such as forward foreign currency exchange contracts, the fair value of which was not material as of December 31, 2014. Our forward foreign currency exchange contracts outstanding as of December 31, 2014, had a notional value of $504 million to hedge our non-U.S. dollar net balance sheet exposures, including $183 million to sell Japanese yen, $163 million to sell euros and $29 million to sell British pound sterling. Prior to the second quarter of 2013, we also held interest rate swaps. See Note 12 for more details.

Our investments in cash equivalents, short-term investments and certain long-term investments, as well as our postretirement plan assets and deferred compensation liabilities, are carried at fair value. The carrying values for other current financial assets and liabilities, such as accounts receivable and accounts payable, approximate fair value due to the short maturity of such instruments. The carrying value of our long-term debt approximates the fair value as measured using broker-dealer quotes, which are Level 2 inputs. See Note 9 for a description of fair value and the definition of Level 2 inputs.

Risk concentration

We are subject to counterparty risk from financial institutions, customers and issuers of debt securities. Financial instruments that could subject us to concentrations of credit risk are primarily cash deposits, cash equivalents, short-term investments and accounts receivable. To manage our credit risk exposure, we place cash investments in investment-grade debt securities and limit the amount of credit exposure to any one issuer. We also limit counterparties on cash deposits and financial derivative contracts to financial institutions with investment-grade ratings.

Concentrations of credit risk with respect to accounts receivable are limited due to our large number of customers and their dispersion across different industries and geographic areas. We maintain allowances for expected returns, disputes, adjustments, incentives and collectability. These allowances are deducted from accounts receivable on our Consolidated Balance Sheets.

Details of these accounts receivable allowances are as follows:



	2014			2013			2012
Balance, January 1	$	22		$	31		$	19
Additions charged (credited) to operating results	(9		)	(9		)	12
Recoveries and write-offs, net	(1		)	—			—
Balance, December 31	$	12		$	22		$	31

Valuation of debt and equity investments and certain liabilities

12 Months Ended

Dec. 31, 2014

Fair Value Disclosures [Abstract]

Valuation of debt and equity investments and certain liabilities

Debt and equity investments

We classify our investments as either available for sale, trading, equity method or cost method. Most of our investments are classified as available for sale.

Available-for-sale and trading securities are stated at fair value, which is generally based on market prices or broker quotes. See fair-value discussion below. Unrealized gains and losses on available-for-sale securities are recorded as an increase or decrease, net of taxes, in AOCI on our Consolidated Balance Sheets. We record other-than-temporary impairments on available-for-sale securities in OI&E in our Consolidated Statements of Income.

We classify certain mutual funds as trading securities. These mutual funds hold a variety of debt and equity investments intended to generate returns that offset changes in certain deferred compensation liabilities. We record changes in the fair value of these mutual funds and the related deferred compensation liabilities in SG&A.

Our other investments are not measured at fair value but are accounted for using either the equity method or cost method. These investments consist of interests in venture capital funds and other non-marketable equity securities. Gains and losses from equity-method investments are reflected in OI&E based on our ownership share of the investee’s financial results. Gains and losses on cost-method investments are recorded in OI&E when realized or when an impairment of the investment’s value is warranted based on our assessment of the recoverability of each investment.

Details of our investments are as follows:



	December 31, 2014						December 31, 2013
	Cash and Cash Equivalents		Short-Term Investments		Long-Term Investments		Cash and Cash Equivalents		Short-Term Investments		Long-Term Investments
Measured at fair value:
Available-for-sale securities
Money market funds	$	522	$	—	$	—	$	500	$	—	$	—
Corporate obligations	97		390		—		123		217		—
U.S. Government agency and Treasury securities	365		1,952		—		787		1,985		—
Trading securities
Mutual funds	—		—		185		—		—		179
Total	984		2,342		185		1,410		2,202		179

Other measurement basis:
Equity-method investments	—		—		27		—		—		24
Cost-method investments	—		—		12		—		—		13
Cash on hand	215		—		—		217		—		—
Total	$	1,199	$	2,342	$	224	$	1,627	$	2,202	$	216

At December 31, 2014 and 2013, we had no significant unrealized gains or losses associated with our available-for-sale investments. We did not recognize any credit losses related to available-for-sale investments for the years ended December 31, 2014, 2013 and 2012.

For the years ended December 31, 2014, 2013 and 2012, the proceeds from sales, redemptions and maturities of short-term available-for-sale investments were $2.97 billion, $4.25 billion and $2.20 billion, respectively. Gross realized gains and losses from these sales were not significant.

The following table presents the aggregate maturities of investments in debt securities classified as available for sale at December 31, 2014:



Due	Fair Value
One year or less	$	3,121
One to two years	205

Gross realized gains and losses from sales of long-term investments were not significant for 2014, 2013 and 2012. Other-than-temporary declines and impairments in the values of these investments recognized in OI&E were not material in 2014, and were $5 million and $7 million in 2013 and 2012, respectively.

Fair-value considerations

We measure and report certain financial assets and liabilities at fair value on a recurring basis. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date.

The three-level hierarchy discussed below indicates the extent and level of judgment used to estimate fair-value measurements.


•	Level 1 - Uses unadjusted quoted prices that are available in active markets for identical assets or liabilities as of the reporting date.

•

Level 2 - Uses inputs other than Level 1 that are either directly or indirectly observable as of the reporting date through correlation with market data, including quoted prices for similar assets and liabilities in active markets and quoted prices in markets that are not active. Level 2 also includes assets and liabilities that are valued using models or other pricing methodologies that do not require significant judgment since the input assumptions used in the models, such as interest rates and volatility factors, are corroborated by readily observable data. We utilize a third-party data service to provide Level 2 valuations. We verify these valuations for reasonableness relative to unadjusted quotes obtained from brokers or dealers based on observable prices for similar assets in active markets.


•	Level 3 - Uses inputs that are unobservable, supported by little or no market activity and reflect the use of significant management judgment. These values are generally determined using pricing models that utilize management estimates of market participant assumptions.

The following are our assets and liabilities that were accounted for at fair value on a recurring basis as of December 31, 2014 and 2013. We had no Level 3 assets or liabilities as of December 31, 2014 and 2013. These tables do not include cash on hand, assets held by our postretirement plans, or assets and liabilities that are measured at historical cost or any basis other than fair value.



	Fair Value December 31, 2014		Level 1		Level 2
Assets:
Money market funds	$	522	$	522	$	—
Corporate obligations	487		—		487
U.S. Government agency and Treasury securities	2,317		1,762		555
Mutual funds	185		185		—
Total assets	$	3,511	$	2,469	$	1,042

Liabilities:
Deferred compensation	$	202	$	202	$	—
Total liabilities	$	202	$	202	$	—



	Fair Value December 31, 2013		Level 1		Level 2
Assets:
Money market funds	$	500	$	500	$	—
Corporate obligations	340		—		340
U.S. Government agency and Treasury securities	2,772		2,107		665
Mutual funds	179		179		—
Total assets	$	3,791	$	2,786	$	1,005

Liabilities:
Deferred compensation	$	197	$	197	$	—
Total liabilities	$	197	$	197	$	—

Goodwill and acquisition-related intangibles

12 Months Ended

Dec. 31, 2014

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill and acquisition-related intangibles

The following table summarizes goodwill, net, by segment for the years ended December 31, 2014 and 2013.



	Goodwill
Analog	$	4,158
Embedded Processing	172
Other	32
Total	$	4,362

We perform our annual goodwill impairment test as of October 1 and determine whether the fair value of each of our reporting units is in excess of its carrying value. Determination of fair value is based upon management estimates and judgment, using unobservable inputs in discounted cash flow models to calculate the fair value of each reporting unit. These unobservable inputs are considered Level 3 measurements. For the years ended December 31, 2014 and 2013, we determined no impairment was indicated. See Note 9 for additional information.

In November 2012, as a result of unsuccessful efforts to divest certain Wireless product lines and the subsequent decision to restructure and wind down those product lines, we reassessed the recoverability of the goodwill associated with the former Wireless segment. As a result, we recognized a non-cash, non-tax deductible impairment charge of $90 million for that goodwill. We recognized this impairment in Restructuring charges/other in the Consolidated Statements of Income, as discussed in Note 4. As of December 31, 2014 and 2013, the accumulated impairment of goodwill was $90 million.

The components of acquisition-related intangible assets as of December 31, 2014 and 2013, are as follows:



		December 31, 2014						December 31, 2013
Acquisition-Related Intangibles	Amortization Period (Years)	Gross Carrying Amount		Accumulated Amortization		Net		Gross Carrying Amount		Accumulated Amortization		Net
Developed technology	5 - 10	$	2,135	$	714	$	1,421	$	2,157	$	526	$	1,631
Customer relationships	8	810		330		480		821		239		582
Other intangibles	5	3		2		1		5		3		2
In-process R&D	n/a	—		n/a		—		8		n/a		8
Total		$	2,948	$	1,046	$	1,902	$	2,991	$	768	$	2,223

Amortization of acquisition-related intangibles was $321 million, $336 million and $342 million for 2014, 2013 and 2012, respectively, primarily related to developed technology. Fully amortized assets are written off against accumulated amortization. Future estimated amortization of acquisition-related intangibles for the years ended December 31 is as follows:



	Amortization of Acquisition-Related Intangibles
2015	$	319
2016	319
2017	318
2018	318
2019	288
Thereafter	340

- Definition

The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.

+ References + Details

Postretirement benefit plans

12 Months Ended

Dec. 31, 2014

Compensation and Retirement Disclosure [Abstract]

Postretirement benefit plans

Plan descriptions

We have various employee retirement plans, including defined contribution, defined benefit and retiree health care benefit plans. For qualifying employees, we offer deferred compensation arrangements.

U.S. retirement plans

Our principal retirement plans in the U.S. are a defined contribution plan; an enhanced defined contribution plan; and qualified and non-qualified defined benefit pension plans. The defined benefit plans were closed to new participants in 1997, and current participants were allowed to make a one-time election to continue accruing a benefit in the plans, or to cease accruing a benefit and instead to participate in the enhanced defined contribution plan described below.

Both defined contribution plans offer an employer-matching savings option that allows employees to make pre-tax contributions to various investment choices, including a TI common stock fund. Employees who elected to continue accruing a benefit in the qualified defined benefit pension plans may also participate in the defined contribution plan, where employer-matching contributions are provided for up to 2 percent of the employee’s annual eligible earnings. Employees who elected not to continue accruing a benefit in the defined benefit pension plans, and employees hired after November 1997 and through December 31, 2003, may participate in the enhanced defined contribution plan. This plan provides for a fixed employer contribution of 2 percent of the employee’s annual eligible earnings, plus an employer-matching contribution of up to 4 percent of the employee’s annual eligible earnings. Employees hired after December 31, 2003, do not receive the fixed employer contribution of 2 percent of the employee’s annual eligible earnings.

At December 31, 2014 and 2013, as a result of employees’ elections, TI’s U.S. defined contribution plans held shares of TI common stock totaling 14 million shares and 15 million shares valued at $740 million and $678 million, respectively. Dividends paid on these shares for 2014 and 2013 were $19 million and $18 million, respectively.

Our aggregate expense for the U.S. defined contribution plans was $60 million in 2014, $62 million in 2013 and $70 million in 2012.

The defined benefit pension plans include employees still accruing benefits, as well as employees and participants who no longer accrue service-related benefits, but instead, may participate in the enhanced defined contribution plan. Benefits under the qualified defined benefit pension plan are determined using a formula based upon years of service and the highest five consecutive years of compensation. We intend to contribute amounts to this plan to meet the minimum funding requirements of applicable local laws and regulations, plus such additional amounts as we deem appropriate. The non-qualified defined benefit plans are unfunded and closed to new participants.

U.S. retiree health care benefit plan

U.S. employees who meet eligibility requirements are offered medical coverage during retirement. We make a contribution toward the cost of those retiree medical benefits for certain retirees and their dependents. The contribution rates are based upon various factors, the most important of which are an employee’s date of hire, date of retirement, years of service and eligibility for Medicare benefits. The balance of the cost is borne by the plan’s participants. Employees hired after January 1, 2001, are responsible for the full cost of their medical benefits during retirement.

Non-U.S. retirement plans

We provide retirement coverage for non-U.S. employees, as required by local laws or to the extent we deem appropriate, through a number of defined benefit and defined contribution plans. Retirement benefits are generally based on an employee’s years of service and compensation. Funding requirements are determined on an individual country and plan basis and are subject to local country practices and market circumstances.

As of December 31, 2014 and 2013, as a result of employees’ elections, TI’s non-U.S. defined contribution plans held TI common stock valued at $17 million and $15 million, respectively. Dividends paid on these shares of TI common stock for 2014 and 2013 were not material.

Effects on the Consolidated Statements of Income and Balance Sheets

Expense related to defined benefit and retiree health care benefit plans was as follows:



	U.S. Defined Benefit									U.S. Retiree Health Care									Non-U.S. Defined Benefit
	2014			2013			2012			2014			2013			2012			2014			2013			2012
Service cost	$	21		$	26		$	24		$	4		$	5		$	5		$	39		$	41		$	45
Interest cost	45			45			44			22			20			25			68			61			75
Expected return on plan assets	(42		)	(48		)	(50		)	(20		)	(24		)	(23		)	(80		)	(67		)	(78		)
Amortization of prior service cost (credit)	—			1			1			4			4			3			(2		)	(3		)	(4		)
Recognized net actuarial loss	26			21			16			7			11			13			24			31			41
Net periodic benefit costs	50			45			35			17			16			23			49			63			79

Settlement losses (a) (b)	5			41			—			—			—			—			1			4			193
Curtailment gain	—			—			—			—			—			(1		)	(2		)	(7		)	—
Special termination benefit gains (b)	—			—			(1		)	—			—			—			—			—			(337		)
Total, including other postretirement losses (gains)	$	55		$	86		$	34		$	17		$	16		$	22		$	48		$	60		$	(65	)

(a) Includes non-restructuring and restructuring-related settlement losses.

(b) Transfer of Japan substitutional pension in 2012: In Japan, we maintain employee pension fund plans (EPFs) pursuant to the Japanese Welfare Pension Insurance Law (JWPIL). An EPF consists of two portions: a substitutional portion based on JWPIL-determined minimum old-age pension benefits similar to Social Security benefits in the United States and a corporate portion established at the discretion of each employer. Employers and employees are exempt from contributing to the Japanese Pension Insurance (JPI) if the substitutional portion is funded by an EPF.

The JWPIL was amended to permit each EPF to separate the substitutional portion and transfer those obligations and related assets to the government of Japan. After such a transfer, the employer is required to contribute periodically to JPI, and the government of Japan is responsible for future benefit payments relating to the substitutional portion.

During the third quarter of 2012, our EPF received final approval for such a separation and transferred the obligations and assets of its substitutional portion to the government of Japan. On a pre-tax basis, this resulted in a net gain of $144 million recorded in Restructuring charges/other on our Consolidated Statements of Income and included in Other, as shown in Note 4. This net gain of $144 million consisted of two parts - a gain of $337 million, representing the difference between the fair values of the obligations settled of $533 million and the assets transferred from the pension trust to the government of Japan of $196 million, offset by a settlement loss of $193 million related to the recognition of previously unrecognized actuarial losses included in AOCI.

For the U.S. qualified pension and retiree health care plans, the expected return on plan assets component of net periodic benefit cost is based upon a market-related value of assets. In accordance with U.S. GAAP, the market-related value of assets is the fair value adjusted by a smoothing technique whereby certain gains and losses are phased in over a period of three years.

Changes in the benefit obligations and plan assets for the defined benefit and retiree health care benefit plans were as follows:



	U.S. Defined Benefit						U.S. Retiree Health Care						Non-U.S. Defined Benefit
	2014			2013			2014			2013			2014			2013
Change in plan benefit obligation:
Benefit obligation at beginning of year	$	955		$	1,098		$	472		$	509		$	2,276		$	2,414
Service cost	21			26			4			5			39			41
Interest cost	45			45			22			20			68			61
Participant contributions	—			—			19			18			5			1
Benefits paid	(66		)	(9		)	(45		)	(47		)	(84		)	(81		)
Medicare subsidy	—			—			4			3			—			—
Actuarial loss (gain)	133			(27		)	37			(36		)	275			96
Settlements	(12		)	(178		)	—			—			(7		)	(30		)
Curtailments	—			—			—			—			(11		)	(28		)
Effects of exchange rate changes	—			—			—			—			(245		)	(237		)
Other	—			—			—			—			—			39
Benefit obligation at end of year (BO)	$	1,076		$	955		$	513		$	472		$	2,316		$	2,276

Change in plan assets:
Fair value of plan assets at beginning of year	$	941		$	1,071		$	485		$	517		$	2,179		$	2,218
Actual return on plan assets	132			1			24			41			295			201
Employer contributions (funding of qualified plans)	75			43			10			—			64			62
Employer contributions (payments for non-qualified plans)	12			13			—			—			—			—
Participant contributions	—			—			19			18			5			1
Benefits paid	(66		)	(9		)	(45		)	(45		)	(84		)	(81		)
Medicare subsidy	—			—			4			—			—			—
Settlements	(12		)	(178		)	—			—			(7		)	(30		)
Effects of exchange rate changes	—			—			—			—			(239		)	(232		)
Other	—			—			—			(46		)	—			40
Fair value of plan assets at end of year (FVPA)	$	1,082		$	941		$	497		$	485		$	2,213		$	2,179

Funded status (FVPA – BO) at end of year	$	6		$	(14	)	$	(16	)	$	13		$	(103	)	$	(97	)

Amounts recognized on the Consolidated Balance Sheets as of December 31, 2014, were as follows:



	U.S. Defined Benefit			U.S. Retiree Health Care			Non-U.S. Defined Benefit			Total
Overfunded retirement plans	$	72		$	—		$	55		$	127
Accrued expenses and other liabilities	(9		)	—			(6		)	(15		)
Underfunded retirement plans	(57		)	(16		)	(152		)	(225		)
Funded status (FVPA – BO) at end of year	$	6		$	(16	)	$	(103	)	$	(113	)

Amounts recognized on the Consolidated Balance Sheets as of December 31, 2013, were as follows:



	U.S. Defined Benefit			U.S. Retiree Health Care			Non-U.S. Defined Benefit			Total
Overfunded retirement plans	$	44		$	16		$	70		$	130
Accrued expenses and other liabilities	(7		)	—			(5		)	(12		)
Underfunded retirement plans	(51		)	(3		)	(162		)	(216		)
Funded status (FVPA – BO) at end of year	$	(14	)	$	13		$	(97	)	$	(98	)

Contributions to the plans meet or exceed all minimum funding requirements. We expect to contribute about $100 million to our retirement benefit plans in 2015. The amounts shown for underfunded U.S. defined benefit plans were for non-qualified pension plans, which we do not fund because contributions to them are not tax deductible.

Accumulated benefit obligations, which are generally less than the projected benefit obligations as they exclude the impact of future salary increases, were $968 million and $882 million at December 31, 2014 and 2013, respectively, for the U.S. defined benefit plans, and $2.15 billion and $2.12 billion at December 31, 2014 and 2013, respectively, for the non-U.S. defined benefit plans.

The amounts recorded in AOCI for the years ended December 31, 2014 and 2013, are detailed below by plan type:



	U.S. Defined Benefit						U.S. Retiree Health Care						Non-U.S. Defined Benefit						Total
	Net Actuarial Loss			Prior Service Credit			Net Actuarial Loss			Prior Service Cost			Net Actuarial Loss			Prior Service Credit			Net Actuarial Loss			Prior Service Credit
AOCI balance, net of taxes, December 31, 2013	$	149		$	(2	)	$	71		$	10		$	305		$	(9	)	$	525		$	(1	)
Changes in AOCI by category
Adjustments	37			—			29			—			5			1			71			1
Recognized within Net income	(31		)	3			(7		)	(3		)	(25		)	—			(63		)	—
Tax effect	(2		)	(1		)	(8		)	1			6			—			(4		)	—
Total change to AOCI	4			2			14			(2		)	(14		)	1			4			1
AOCI balance, net of taxes, December 31, 2014	$	153		$	—		$	85		$	8		$	291		$	(8	)	$	529		$	—

The estimated amounts of net actuarial loss and unrecognized prior service cost (credit) included in AOCI as of December 31, 2014, that are expected to be amortized into net periodic benefit cost over the next fiscal year are: $19 million and none for the U.S. defined benefit plans; $9 million and $6 million for the U.S. retiree health care benefit plan; and $22 million and ($2) million for the non-U.S. defined benefit plans.

Information on plan assets

We report and measure the plan assets of our defined benefit pension and other postretirement plans at fair value. The tables below set forth the fair value of our plan assets as of December 31, 2014 and 2013, using the same three-level hierarchy of fair-value inputs described in Note 9.



	Fair Value December 31, 2014		Level 1		Level 2		Level 3
Assets of U.S. defined benefit plan
Fixed income securities and cash equivalents	$	707	$	—	$	707	$	—
Equity securities	375		—		375		—
Other	—		—		—		—
Total	$	1,082	$	—	$	1,082	$	—

Assets of U.S. retiree health care plan
Fixed income securities and cash equivalents	$	243	$	200	$	43	$	—
Equity securities	254		—		254		—
Total	$	497	$	200	$	297	$	—

Assets of non-U.S. defined benefit plans
Fixed income securities and cash equivalents	$	1,608	$	430	$	1,178	$	—
Equity securities	600		6		594		—
Other	5		—		—		5
Total	$	2,213	$	436	$	1,772	$	5



	Fair Value December 31, 2013		Level 1		Level 2		Level 3
Assets of U.S. defined benefit plan
Fixed income securities and cash equivalents	$	607	$	—	$	607	$	—
Equity securities	297		—		297		—
Other	37		—		—		37
Total	$	941	$	—	$	904	$	37

Assets of U.S. retiree health care plan
Fixed income securities and cash equivalents	$	238	$	193	$	45	$	—
Equity securities	247		—		247		—
Total	$	485	$	193	$	292	$	—

Assets of non-U.S. defined benefit plans
Fixed income securities and cash equivalents	$	1,521	$	397	$	1,124	$	—
Equity securities	650		6		644		—
Other	8		—		—		8
Total	$	2,179	$	403	$	1,768	$	8

The investments in our major benefit plans largely consist of low-cost, broad-market index funds to mitigate risks of concentration within market sectors. Our investment policy is designed to better match the interest rate sensitivity of the plan assets and liabilities. The appropriate mix of equity and bond investments is determined primarily through the use of detailed asset-liability modeling studies that look to balance the impact of changes in the discount rate against the need to provide asset growth to cover future service cost. Most of our plans around the world have a greater proportion of fixed income securities with return characteristics that are more closely aligned with changes in the liabilities caused by discount rate volatility. For the U.S. plans, we utilize an option collar strategy to reduce the volatility of returns on investments in U.S. equity funds.

The only Level 3 assets in our worldwide benefit plans for the periods presented are private equity limited partnerships in our U.S. pension plan, which were sold in 2014, and a diversified property fund in a non-U.S. pension plan. These investments are valued using inputs from the fund managers and internal models. The following table summarizes the change in the fair values for Level 3 plan assets for the years ending December 31, 2014 and 2013:



	Level 3 Plan Assets
	U.S. Defined Benefit			Non-U.S. Defined Benefit
Balance, December 31, 2012	$	37		$	19
Redemptions	—			(10		)
Unrealized loss	—			(1		)
Balance, December 31, 2013	37			8
Redemptions and sales	(45		)	(2		)
Unrealized gain (loss)	8			(1		)
Balance, December 31, 2014	$	—		$	5

Assumptions and investment policies



	Defined Benefit		U.S. Retiree Health Care
	2014	2013	2014	2013
Weighted average assumptions used to determine benefit obligations:
U.S. discount rate	4.23%	5.11%	4.07%	4.83%
Non-U.S. discount rate	2.34%	3.01%

U.S. average long-term pay progression	3.30%	3.50%
Non-U.S. average long-term pay progression	3.27%	3.11%

Weighted average assumptions used to determine net periodic benefit cost:
U.S. discount rate	5.11%	4.59%	4.83%	3.94%
Non-U.S. discount rate	3.01%	2.74%

U.S. long-term rate of return on plan assets	5.25%	5.25%	4.50%	4.75%
Non-U.S. long-term rate of return on plan assets	3.75%	3.34%

U.S. average long-term pay progression	3.50%	3.60%
Non-U.S. average long-term pay progression	3.11%	3.01%

We utilize a variety of methods to select an appropriate discount rate depending on the depth of the corporate bond market in the country in which the benefit plan operates. In the United States, we use a settlement approach whereby a portfolio of bonds is selected from the universe of actively traded high-quality U.S. corporate bonds. The selected portfolio is designed to provide cash flows sufficient to pay the plan’s expected benefit payments when due. The resulting discount rate reflects the rate of return of the selected portfolio of bonds. For our non-U.S. locations with a sufficient number of actively traded high-quality bonds, an analysis is performed in which the projected cash flows from the defined benefit plans are discounted against a yield curve constructed with an appropriate universe of high-quality corporate bonds available in each country. In this manner, a present value is developed. The discount rate selected is the single equivalent rate that produces the same present value. For countries that lack a sufficient corporate bond market, a government bond index adjusted for an appropriate risk premium is used to establish the discount rate.

Assumptions for the expected long-term rate of return on plan assets are based on future expectations for returns for each asset class and the effect of periodic target asset allocation rebalancing. We adjust the results for the payment of reasonable expenses of the plan from plan assets. We believe our assumptions are appropriate based on the investment mix and long-term nature of the plans’ investments. Assumptions used for the non-U.S. defined benefit plans reflect the different economic environments within the various countries.

The table below shows target allocation ranges for the plans that hold a substantial majority of the defined benefit assets.



Asset Category	U.S. Defined Benefit	U.S. Retiree Health Care	Non-U.S. Defined Benefit
Fixed income securities and cash equivalents	65%	50%	60% - 100%
Equity securities	35%	50%	0% - 40%

We rebalance the plans’ investments when they are not within the target allocation ranges.

Weighted average asset allocations as of December 31, are as follows:



	U.S. Defined Benefit		U.S. Retiree Health Care		Non-U.S. Defined Benefit
Asset Category	2014	2013	2014	2013	2014	2013
Fixed income securities and cash equivalents	65%	65%	49%	49%	73%	70%
Equity securities	35%	35%	51%	51%	27%	30%

None of the plan assets related to the defined benefit pension plans and retiree health care benefit plan are directly invested in TI common stock. As of December 31, 2014, we do not expect to return any of the defined benefit pension plans’ assets to TI in the next 12 months.

The following table shows the benefits we expect to pay to participants from the plans in the next 10 years and assumes that retirement eligible participants take their benefits immediately. Almost all of the payments will be made from plan assets and not from company assets.



	U.S. Defined Benefit		U.S. Retiree Health Care		Medicare Subsidy			Non-U.S. Defined Benefit
2015	$	217	$	36	$	(4	)	$	76
2016	95		37		(4		)	78
2017	91		39		(4		)	82
2018	93		40		(5		)	85
2019	93		40		(5		)	89
2020 - 2024	435		194		(9		)	501

Assumed health care cost trend rates for the U.S. retiree health care benefit plan at December 31 are as follows:



	2014	2013
Assumed health care cost trend rate for next year	7.0%	7.0%
Ultimate trend rate	5.0%	5.0%
Year in which ultimate trend rate is reached	2023	2022

A one percentage point increase or decrease in health care cost trend rates over all future periods would have increased or decreased the accumulated postretirement benefit obligation for the U.S. retiree health care benefit plan at December 31, 2014, by $27 million or $22 million, respectively. The service cost and interest cost components of 2014 plan expense would have increased or decreased by $1 million.

Deferred compensation arrangements

We have a deferred compensation plan that allows U.S. employees whose base salary and management responsibility exceed a certain level to defer receipt of a portion of their cash compensation. Payments under this plan are made based on the participant’s distribution election and plan balance. Participants can earn a return on their deferred compensation based on notional investments in the same investment funds that are offered in our defined contribution plans.

As of December 31, 2014, our liability to participants of the deferred compensation plans was $202 million and is recorded in Deferred credits and other liabilities on our Consolidated Balance Sheets. This amount reflects the accumulated participant deferrals and earnings thereon as of that date. As of December 31, 2014, we held $185 million in mutual funds related to these plans that are recorded in Long-term investments on our Consolidated Balance Sheets, and serve as an economic hedge against changes in fair values of our other deferred compensation liabilities. We record changes in the fair value of the liability and the related investment in SG&A as discussed in Note 9.

Debt and lines of credit

12 Months Ended

Dec. 31, 2014

Debt Disclosure [Abstract]

Debt and lines of credit

Short-term borrowings

We maintain a line of credit to support commercial paper borrowings, if any, and to provide additional liquidity through bank loans. As of December 31, 2014, we had a variable-rate revolving credit facility from a consortium of investment-grade banks that allows us to borrow up to $2 billion through March 2019. The interest rate on borrowings under this credit facility, if drawn, is indexed to the applicable London Interbank Offered Rate (LIBOR). As of December 31, 2014, our credit facility was undrawn and we had no commercial paper outstanding.

Long-term debt

In March 2014, we issued an aggregate principal amount of $500 million of fixed-rate long-term debt, with $250 million due in 2017 and $250 million due in 2021. We incurred $3 million of issuance and other related costs, which are being amortized to Interest and debt expense over the term of the debt. The proceeds of the offering were $498 million, net of the original issuance discount and were used toward the repayment of the $1.0 billion of debt that matured in May 2014.

In May 2013, we issued an aggregate principal amount of $1.0 billion of fixed-rate long-term debt, with $500 million due in 2018 and $500 million due in 2023. We incurred $6 million of issuance and other related costs that are being amortized to Interest and debt expense over the term of the debt. The proceeds of the offering were $986 million, net of the original issuance discount and were used toward the repayment of $1.5 billion of maturing debt, including floating-rate notes. In connection with this repayment, we settled a floating-to-fixed interest rate swap, associated with the maturing debt.

In August 2012, we issued an aggregate principal amount of $1.5 billion of fixed-rate long-term debt, with $750 million due in 2015 and $750 million due in 2019. The proceeds of the offering were $1.492 billion, net of the original issuance discount. We also incurred $7 million of issuance and other related costs that are being amortized to Interest and debt expense over the term of the debt.

Long-term debt outstanding as of December 31, 2014 and 2013 is as follows:



	December 31,
	2014			2013
Notes due 2014 at 1.375%	$	—		$	1,000
Notes due 2015 at 3.95% (assumed with National acquisition)	250			250
Notes due 2015 at 0.45%	750			750
Notes due 2016 at 2.375%	1,000			1,000
Notes due 2017 at 6.60% (assumed with National acquisition)	375			375
Notes due 2017 at 0.875%	250			—
Notes due 2018 at 1.00%	500			500
Notes due 2019 at 1.65%	750			750
Notes due 2021 at 2.75%	250			—
Notes due 2023 at 2.25%	500			500
	4,625			5,125
Net unamortized premium	17			33
Current portion of long-term debt	(1,001		)	(1,000		)
Long-term debt	$	3,641		$	4,158

Interest and debt expense was $94 million in 2014, $95 million in 2013 and $85 million in 2012. This was net of the amortization of the debt premium and other debt issuance costs. Cash payments for interest on long-term debt were $102 million in both 2014 and 2013 and $97 million in 2012. Capitalized interest was not material.

Commitments and contingencies

12 Months Ended

Dec. 31, 2014

Commitments and Contingencies Disclosure [Abstract]

Commitments and contingencies

Operating leases

We conduct certain operations in leased facilities and also lease a portion of our data processing and other equipment. In addition, certain long-term supply agreements to purchase industrial gases are accounted for as operating leases. Lease agreements frequently include purchase and renewal provisions and require us to pay taxes, insurance and maintenance costs. Rental and lease expense incurred was $113 million, $120 million and $124 million in 2014, 2013 and 2012, respectively.

Capitalized software licenses

We have licenses for certain internal-use electronic design automation software that we account for as capital leases. The related liabilities are apportioned between Accounts payable and Deferred credits and other liabilities on our Consolidated Balance Sheets, depending on the contractual timing of payments.

Purchase commitments

Some of our purchase commitments entered in the ordinary course of business provide for minimum payments.

As of December 31, 2014, we had committed to make the following minimum payments under our non-cancellable operating leases, capitalized software licenses and purchase commitments:



	Operating Leases		Capitalized Software Licenses		Purchase Commitments
2015	$	87	$	39	$	96
2016	66		27		52
2017	45		—		35
2018	33		—		14
2019	21		—		10
Thereafter	80		—		2

Indemnification guarantees

We routinely sell products with an intellectual property indemnification included in the terms of sale. Historically, we have had only minimal, infrequent losses associated with these indemnities. Consequently, we cannot reasonably estimate any future liabilities that may result.

Warranty costs/product liabilities

We accrue for known product-related claims if a loss is probable and can be reasonably estimated. During the periods presented, there have been no material accruals or payments regarding product warranty or product liability. Historically, we have experienced a low rate of payments on product claims. Although we cannot predict the likelihood or amount of any future claims, we do not believe they will have a material adverse effect on our financial condition, results of operations or liquidity. Consistent with general industry practice, we enter into formal contracts with certain customers that include negotiated warranty remedies. Typically, under these agreements our warranty for semiconductor products includes three years of coverage; an obligation to repair, replace or refund; and a maximum payment obligation tied to the price paid for our products. In some cases, product claims may exceed the price of our products.

General

We are subject to various legal and administrative proceedings. Although it is not possible to predict the outcome of these matters, we believe that the results of these proceedings will not have a material adverse effect on our financial condition, results of operations or liquidity.

Discontinued operations indemnity

In connection with the 2006 sale of the former Sensors & Controls (S&C) business, we have agreed to indemnify Sensata Technologies, Inc., for specified litigation matters and certain liabilities, including environmental liabilities. In a settlement with a third party, we have agreed to indemnify that party for certain events relating to S&C products, which events we consider remote. We believe our total remaining potential exposure from both of these indemnities will not exceed $200 million. As of December 31, 2014, we believe future payments related to these indemnity obligations will not have a material effect on our financial condition, results of operations or liquidity.

Supplemental financial information

12 Months Ended

Dec. 31, 2014

Supplemental Financial Information [Abstract]

Supplemental financial information

Other Income (Expense), Net



	For Years Ended December 31,
	2014		2013			2012
Interest income	$	7	$	10		$	8
Tax interest income (expense)	6		(10		)	32
Net gains on investments	5		18			18
Other (a)	3		(1		)	(11		)
Total	$	21	$	17		$	47

(a) Includes lease income of approximately $15 million per year, primarily from the purchaser of a former business. As of December 31, 2014, the aggregate amount of non-cancellable future lease payments to be received from these leases is $51 million. These leases contain renewal options. Other also includes miscellaneous non-operational items such as losses related to former businesses, including settlements in 2012; gains and losses from currency exchange rate changes; and gains and losses from our derivative financial instruments, primarily forward foreign currency exchange contracts.

Prepaid Expenses and Other Current Assets



	December 31,
	2014		2013
Prepaid taxes on intercompany inventory profits	$	693	$	667
Other prepaid expenses and current assets	157		196
Total	$	850	$	863

Property, Plant and Equipment at Cost



	Depreciable Lives (Years)	December 31,
	Depreciable Lives (Years)	2014		2013
Land	n/a	$	137	$	175
Buildings and improvements	5 - 40	2,801		2,913
Machinery and equipment	3 - 10	3,328		3,468
Total		$	6,266	$	6,556

Accrued Expenses and Other Liabilities



	December 31,
	2014		2013
Customer incentive programs and allowances	$	101	$	143
Severance and related expenses	60		158
Other	337		350
Total	$	498	$	651

Accumulated Other Comprehensive Income (Loss), Net of Taxes



	December 31,
	2014			2013
Postretirement benefit plans:
Net actuarial loss	$	(529	)	$	(525	)
Prior service credit	—			1
Cash flow hedge derivative	(3		)	(4		)
Total	$	(532	)	$	(528	)

Details on amounts reclassified out of Accumulated other comprehensive income (loss), net of taxes to Net income

Our Consolidated Statements of Comprehensive Income include items that have been recognized within Net income during the years ended December 31, 2014 and 2013. The table below details where on the Consolidated Statements of Income these transactions are recorded.



	For Years Ended December 31,						Impact to Related Statement of Income Line
Details about AOCI Components	2014			2013			Impact to Related Statement of Income Line
Net actuarial gains (losses) of defined benefit plans:
Recognized net actuarial loss and Settlement losses (a)	$	63		$	108		Increase to Pension expense (b)
Tax effect	(21		)	(37		)	Decrease to Provision for income taxes
Recognized within Net income, net of taxes	$	42		$	71		Decrease to Net income

Prior service cost of defined benefit plans:
Amortization of prior service cost (credit) and Curtailment gain (a)	$	—		$	(5	)	Decrease to Pension expense (b)
Tax effect	—			2			Increase to Provision for income taxes
Recognized within Net income, net of taxes	$	—		$	(3	)	Increase to Net income

Derivative instruments:
Amortization of treasury rate locks	$	2		$	2		Increase to Interest and debt expense
Tax effect	(1		)	(1		)	Decrease to Provision for income taxes
Recognized within Net income, net of taxes	$	1		$	1		Decrease to Net income

(a) Detailed in Note 11.

(b) Pension expense is included in COR, R&D, SG&A and Restructuring charges/other in the Consolidated Statements of Income.

Quarterly financial data (unaudited)

12 Months Ended

Dec. 31, 2014

Quarterly Financial Information Disclosure [Abstract]

Quarterly financial data (unaudited)



	Quarter
2014	1st			2nd			3rd			4th
Revenue	$	2,983		$	3,292		$	3,501		$	3,269
Gross profit	1,607			1,881			2,044			1,895
Included in Operating profit:
Acquisition charges	83			82			83			82
Restructuring charges/other	(11		)	(4		)	(9		)	(27		)
Operating profit	690			982			1,175			1,100
Net income	487			683			826			825

Earnings per common share:
Basic earnings per common share	$	0.44		$	0.63		$	0.77		$	0.78
Diluted earnings per common share	0.44			0.62			0.76			0.76

	Quarter
2013	1st			2nd			3rd			4th
Revenue	$	2,885		$	3,047		$	3,244		$	3,028
Gross profit	1,374			1,570			1,779			1,640
Included in Operating profit:
Acquisition charges	86			86			86			84
Restructuring charges/other	15			(282		)	16			62
Operating profit	395			906			844			687
Net income	362			660			629			511

Earnings per common share:
Basic earnings per common share	$	0.32		$	0.59		$	0.56		$	0.46
Diluted earnings per common share	0.32			0.58			0.56			0.46

Basis of presentation and significant accounting policies and practices (Policies)

12 Months Ended

Dec. 31, 2014

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Basis of presentation

Revenue recognition

We believe we can reasonably and reliably estimate allowances for credits to distributors in a timely manner.

We recognize shipping fees received from customers in revenue, and we include the shipping and handling costs in COR.

Advertising costs

We expense advertising and other promotional costs as incurred.

Restructuring charges

Income taxes

Other assessed taxes

Earnings per share (EPS)

Investments

We present investments on our Consolidated Balance Sheets as cash equivalents, short-term investments or long-term investments. Specific details are as follows:

•


•	Long-term investments: Long-term investments consist of mutual funds, venture capital funds and non-marketable equity securities.


•	Classification of investments: Depending on our reasons for holding the investment and our ownership percentage, we classify our investments as either available for sale, trading, equity method or cost method, which are more fully described in Note 9. We determine cost or amortized cost, as appropriate, on a specific identification basis.

We classify our investments as either available for sale, trading, equity method or cost method. Most of our investments are classified as available for sale.

Inventories

Property, plant and equipment; acquisition-related intangibles and other capitalized costs

Impairments of long-lived assets

Goodwill and indefinite-lived intangibles

Foreign currency

Derivatives and hedging

We do not use derivatives for speculative or trading purposes.

Stock-based compensation

Risk-free interest rates are determined using the implied yield currently available for zero-coupon U.S. government issues with a remaining term equal to the expected life of the options.

The fair value per share of RSUs is determined based on the closing price of our common stock on the date of grant.

Fair value

Fair-value considerations

The three-level hierarchy discussed below indicates the extent and level of judgment used to estimate fair-value measurements.


•	Level 1 - Uses unadjusted quoted prices that are available in active markets for identical assets or liabilities as of the reporting date.

•


•	Level 3 - Uses inputs that are unobservable, supported by little or no market activity and reflect the use of significant management judgment. These values are generally determined using pricing models that utilize management estimates of market participant assumptions.

Indemnification guarantees and Warranty costs/product liabilities

Indemnification guarantees

Warranty costs/product liabilities

Description of business, including segment and geographic area information (Tables)

12 Months Ended

Dec. 31, 2014

Segment Reporting [Abstract]

Schedule of revenue and operating profit, by segment

Segment information



	For Years Ended December 31,
	2014		2013		2012
Revenue:
Analog	$	8,104	$	7,194	$	6,998
Embedded Processing	2,740		2,450		2,257
Other	2,201		2,561		3,570
Total revenue	$	13,045	$	12,205	$	12,825
Operating profit:
Analog	$	2,786	$	1,859	$	1,650
Embedded Processing	384		185		158
Other	777		788		165
Total operating profit	$	3,947	$	2,832	$	1,973

Schedule of revenue, by geographic area

The following geographic area information includes revenue, based on product shipment destination and royalty payor location, and property, plant and equipment, based on physical location:



	For Years Ended December 31,
	2014		2013		2012
Revenue:
United States	$	1,625	$	1,666	$	1,596
Asia (a)	7,915		7,370		7,808
Europe	2,293		1,926		1,861
Japan	1,032		1,072		1,357
Rest of world	180		171		203
Total revenue	$	13,045	$	12,205	$	12,825

(a) Revenue from products shipped into China, including Hong Kong, was $5.7 billion in 2014, $5.2 billion in 2013 and $5.4 billion in 2012.

Schedule property, plant and equipment, net, by geographic area



	December 31,
	2014		2013		2012
Property, plant and equipment, net:
United States	$	1,436	$	1,765	$	1,931
Asia	1,096		1,277		1,547
Europe	162		196		241
Japan	124		144		174
Rest of world	22		17		19
Total property, plant and equipment, net	$	2,840	$	3,399	$	3,912

Basis of presentation and significant accounting policies and practices (Tables)

12 Months Ended

Dec. 31, 2014

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Schedule of earnings per share, basic and diluted

Computation and reconciliation of earnings per common share are as follows (shares in millions):



	For Years Ended December 31,
	2014						2013						2012
	Net Income			Shares	EPS		Net Income			Shares	EPS		Net Income			Shares	EPS
Basic EPS:
Net income	$	2,821					$	2,162					$	1,759
Income allocated to RSUs	(44		)				(37		)				(31		)
Income allocated to common stock for basic EPS calculation	$	2,777		1,065	$	2.61	$	2,125		1,098	$	1.94	$	1,728		1,132	$	1.53

Adjustment for dilutive shares:
Stock-based compensation plans				15						15						14

Diluted EPS:
Net income	$	2,821					$	2,162					$	1,759
Income allocated to RSUs	(43		)				(36		)				(31		)
Income allocated to common stock for diluted EPS calculation	$	2,778		1,080	$	2.57	$	2,126		1,113	$	1.91	$	1,728		1,146	$	1.51

Acquisition charges (Tables)

12 Months Ended

Dec. 31, 2014

Business Combinations [Abstract]

Total acquisition-related charges associated with the National acquisition

Total acquisition-related charges are detailed below:



	For Years Ended December 31,
	2014		2013		2012
Amortization of intangible assets	$	319	$	323	$	325
Stock-based compensation	11		11		17
Retention bonuses	—		7		57
Severance and other benefits	—		—		16
Transaction and other costs	—		—		35
As recorded in Acquisition charges	330		341		450
As recorded in COR	—		—		21
Total acquisition-related charges	$	330	$	341	$	471

Restructuring charges/other (Tables)

12 Months Ended

Dec. 31, 2014

Restructuring and Related Activities [Abstract]

Schedule of restructuring charges/other

Restructuring charges/other is comprised of the following components:



	For Years Ended December 31,
	2014			2013			2012
Restructuring charges by action:
2013 actions
Severance and benefits cost (a)	$	16		$	49		$	—
Other exit costs	10			—			—
	26			49			—
Prior actions
Severance and benefits cost (a)	(6		)	36			251
Accelerated depreciation	1			11			21
Other exit costs (a)	(1		)	30			128
	(6		)	77			400
Total restructuring charges	20			126			400

Other:
Gains on sales of assets	(75		)	—			—
Gain on technology transfer	—			(315		)	—
Gain on transfer of Japan substitutional pension	—			—			(144		)
Other	4			—			8
Restructuring charges/other	$	(51	)	$	(189	)	$	264

(a) Includes changes in estimates.

Changes in accrued restructuring balances

The table below reflects the changes in accrued restructuring balances associated with these actions:



	2013 Actions						Prior Actions
	Severance and Benefits			Other Charges			Severance and Benefits			Other Charges			Total
Accrual at December 31, 2011	$	—		$	—		$	109		$	7		$	116
Restructuring charges (a)	—			—			251			149			400
Non-cash items (b)	—			—			3			(124		)	(121		)
Payments	—			—			(23		)	(23		)	(46		)
Remaining accrual at December 31, 2012	—			—			340			9			349

Restructuring charges (a)	49			—			36			41			126
Non-cash items (b)	—			—			(5		)	(17		)	(22		)
Payments	—			—			(266		)	(26		)	(292		)
Remaining accrual at December 31, 2013	49			—			105			7			161

Restructuring charges (a)	16			10			(6		)	—			20
Payments	(43		)	(1		)	(73		)	(7		)	(124		)
Remaining accrual at December 31, 2014	$	22		$	9		$	26		$	—		$	57

(a) Includes changes in estimates.

(b) Reflects charges for goodwill impairment, stock-based compensation, impacts of postretirement benefit plans and accelerated depreciation.

Stock-based compensation (Tables)

12 Months Ended

Dec. 31, 2014

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Schedule of stock-based compensation expense allocation within the Consolidated Statements of Income

Total stock-based compensation expense recognized was as follows:



	For Years Ended December 31,
	2014		2013		2012
Stock-based compensation expense recognized in:
COR	$	48	$	49	$	48
R&D	62		67		71
SG&A	156		160		127
Acquisition charges	11		11		17
Total	$	277	$	287	$	263

Schedule of weighted average assumptions used to estimate the fair values for non-qualified stock options

We estimate the fair values for non-qualified stock options using the Black-Scholes-Merton option-pricing model with the following weighted average assumptions.



	For Years Ended December 31,
	2014			2013			2012
Weighted average grant date fair value, per share	$	8.13		$	6.78		$	8.31
Weighted average assumptions used:
Expected volatility	22		%	26		%	30		%
Expected lives (in years)	7.3			7.4			7.1
Risk-free interest rates	2.45		%	1.43		%	1.40		%
Expected dividend yields	2.72		%	2.56		%	2.10		%

Schedule of stock option and RSU transactions under long-term incentive and director compensation plans

Stock option and RSU transactions under our long-term incentive and director compensation plans during 2014 were as follows:



	Stock Options				RSUs
	Shares		Weighted Average Exercise Price per Share		Shares		Weighted Average Grant Date Fair Value per Share
Outstanding grants, December 31, 2013	64,930,540		$	28.98	20,892,022		$	29.94
Granted	14,053,185		44.11		3,184,237		44.71
Vested RSUs	—		—		(5,609,627	)	23.68
Forfeited and expired	(1,832,897	)	36.54		(1,162,817	)	33.22
Exercised	(19,503,382	)	27.75		—		—
Outstanding grants, December 31, 2014	57,647,446		32.84		17,303,815		34.47

Schedule of shares outstanding under stock option plans, by exercise price range

Summarized information about stock options outstanding at December 31, 2014, is as follows:



		Stock Options Outstanding				Options Exercisable
Range of Exercise Price		Number Outstanding (Shares)	Weighted Average Remaining Contractual Life (Years)	Weighted Average Exercise Price per Share		Number Exercisable (Shares)	Weighted Average Exercise Price per Share
$	14.47 to 20.00	4,061,577	4.0	$	14.98	4,061,577	$	14.98
	20.01 to 30.00	11,270,125	3.7	25.47		11,250,200	25.46
	30.01 to 40.00	28,910,636	6.5	33.00		12,288,339	33.14
	40.01 to 50.00	13,399,020	9.1	44.10		1,750	42.66
	50.01 to 55.41	6,088	9.9	55.41		—	—
	14.47 to 55.41	57,647,446	6.4	32.84		27,601,866	27.34

Schedule of stock options that are vested and expected to vest, outstanding and exercisable

Summarized information as of December 31, 2014, about outstanding stock options that are vested and expected to vest, as well as stock options that are currently exercisable, is as follows:



	Outstanding Stock Options (Fully Vested and Expected to Vest) (a)		Options Exercisable
Number of outstanding (shares)	56,328,323		27,601,866
Weighted average remaining contractual life (in years)	6.3		4.4
Weighted average exercise price per share	$	32.69	$	27.34
Intrinsic value (millions of dollars)	$	1,170	$	721

Schedule of director deferred compensation payable in shares

Director deferred stock activity during 2014 was as follows:



	Director Deferred Stock (Shares)
Outstanding, December 31, 2013	129,264
New shares deferred	13,636
Issued	(7,178	)
Outstanding, December 31, 2014	135,722

Schedule of employee stock purchase plan transactions

Employee stock purchase plan transactions during 2014 were as follows:



	Employee Stock Purchase Plan (Shares)		Exercise Price
Outstanding grants, December 31, 2013	485,408		$	36.64
Granted	1,673,479		41.60
Exercised	(1,784,184	)	39.44
Outstanding grants, December 31, 2014	374,703		45.46

Schedule of changes in treasury stock

The table below reflects the changes in our treasury shares:



	Stock Options		RSUs		Treasury Shares
Balance, December 31, 2011					601,131,631
Repurchases					59,757,780
Shares used for:
Stock options/RSUs	(22,409,816	)	(4,182,928	)
Previously unissued common shares (a)	180,955		4,593
Stock applied to taxes	—		990,845
ESPP	(2,829,498	)	—
Director deferred stock	—		—		(6,592	)
Total issued	(25,058,359	)	(3,187,490	)	(28,245,849	)
Balance, December 31, 2012					632,636,970

Repurchases					77,564,013
Shares used for:
Stock options/RSUs	(45,507,711	)	(5,741,981	)
Stock applied to taxes	—		1,461,422
ESPP	(2,386,834	)	—
Director deferred stock	—		—		(12,909	)
Total issued	(47,894,545	)	(4,280,559	)	(52,175,104	)
Balance, December 31, 2013					658,012,970

Repurchases					61,665,209
Shares used for:
Stock options/RSUs	(19,503,382	)	(5,609,627	)
Stock applied to exercises or taxes	6,618		1,408,701
ESPP	(1,784,184	)	—
Director deferred stock	—		—		(7,178	)
Total issued	(21,280,948	)	(4,200,926	)	(25,481,874	)
Balance, December 31, 2014					694,189,127

(a) Beginning in 2013, only treasury shares were issued.

Schedule of shares reserved for issuance and available for future grant

Shares available for future grants and reserved for issuance are summarized below:



	December 31, 2014
Shares	Long-Term Incentive and Director Compensation Plans		Employee Stock Purchase Plan		Total
Reserved for issuance (a)	121,127,656		39,565,038		160,692,694
Shares to be issued upon exercise of outstanding options and RSUs (a)	(75,086,983	)	(374,703	)	(75,461,686	)
Available for future grants	46,040,673		39,190,335		85,231,008

(a) Includes 135,722 shares credited to directors’ deferred stock accounts that settle in shares of TI common stock. These shares are not included as grants outstanding at December 31, 2014.

Schedule of cash proceeds received from share-based payment awards

The effects on cash flows were as follows:



	For Years Ended December 31,
	2014		2013		2012
Proceeds from common stock transactions	$	616	$	1,314	$	523
Tax benefit realized from stock options exercised	218		227		133

Income taxes (Tables)

12 Months Ended

Dec. 31, 2014

Income Tax Disclosure [Abstract]

Income before income taxes

Income before Income Taxes



	U.S.		Non-U.S.		Total
2014	$	2,684	$	1,190	$	3,874
2013	1,507		1,247		2,754
2012	319		1,616		1,935

Provision (benefit) for income taxes

Provision (Benefit) for Income Taxes



	U.S. Federal			Non-U.S.		U.S. State			Total
2014
Current	$	911		$	194	$	9		$	1,114
Deferred	(73		)	11		1			(61		)
Total	$	838		$	205	$	10		$	1,053

2013
Current	$	291		$	247	$	4		$	542
Deferred	17			33		—			50
Total	$	308		$	280	$	4		$	592

2012
Current	$	(108	)	$	156	$	(2	)	$	46
Deferred	65			65		—			130
Total	$	(43	)	$	221	$	(2	)	$	176

Principal reconciling items from income tax computed at statutory federal rate

Principal reconciling items from income tax computed at the statutory federal rate follow:



	For Years Ended December 31,
	2014			2013			2012
Computed tax at statutory rate	$	1,356		$	964		$	677
Non-U.S. effective tax rates	(212		)	(156		)	(345		)
U.S. R&D tax credit	(59		)	(129		)	—
U.S. tax benefit for manufacturing	(51		)	(66		)	(158		)
Impact of changes to uncertain tax positions	3			(14		)	(88		)
Non-deductible expenses	6			13			42
Other	10			(20		)	48
Total provision for income taxes	$	1,053		$	592		$	176

Primary components of deferred income tax assets and liabilities

The primary components of deferred income tax assets and liabilities were as follows:



	December 31,
	2014			2013
Deferred income tax assets:
Deferred loss and tax credit carryforwards	$	289		$	345
Accrued expenses	248			265
Stock-based compensation	238			262
Inventories and related reserves	157			162
Retirement costs for defined benefit and retiree health care	96			101
Other	122			148
	1,150			1,283
Valuation allowance	(195		)	(219		)
	955			1,064
Deferred income tax liabilities:
Acquisition-related intangibles and fair-value adjustments	(688		)	(804		)
International earnings	(104		)	(121		)
Property, plant and equipment	(10		)	(57		)
Other	(37		)	(31		)
	(839		)	(1,013		)
Net deferred income tax asset	$	116		$	51

Deferred income tax assets and liabilities presentation on the Balance sheet

The deferred income tax assets and liabilities based on tax jurisdictions are presented on the Consolidated Balance Sheets as follows:



	December 31,
	2014			2013
Current deferred income tax assets	$	347		$	393
Noncurrent deferred income tax assets	172			207
Current deferred income tax liabilities	(4		)	(1		)
Noncurrent deferred income tax liabilities	(399		)	(548		)
Net deferred income tax asset	$	116		$	51

Summary of income tax contingencies

The changes in the total amounts of uncertain tax positions are summarized as follows:



	2014			2013			2012
Balance, January 1	$	91		$	184		$	210
Additions based on tax positions related to the current year	10			7			12
Additions for tax positions of prior years	52			19			45
Reductions for tax positions of prior years	(9		)	(10		)	(92		)
Settlements with tax authorities	(36		)	(96		)	39
Expiration of the statute of limitations for assessing taxes	—			(13		)	(30		)
Balance, December 31	$	108		$	91		$	184

Interest income (expense) recognized in the year ended December 31	$	6		$	(10	)	$	32

Interest receivable (payable) as of December 31	$	—		$	(5	)	$	8

Financial instruments and risk concentration (Tables)

12 Months Ended

Dec. 31, 2014

Risks and Uncertainties [Abstract]

Details on accounts receivable allowances

Details of these accounts receivable allowances are as follows:



	2014			2013			2012
Balance, January 1	$	22		$	31		$	19
Additions charged (credited) to operating results	(9		)	(9		)	12
Recoveries and write-offs, net	(1		)	—			—
Balance, December 31	$	12		$	22		$	31

Valuation of debt and equity investments and certain liabilities (Tables)

12 Months Ended

Dec. 31, 2014

Fair Value Disclosures [Abstract]

Investments

Details of our investments are as follows:



	December 31, 2014						December 31, 2013
	Cash and Cash Equivalents		Short-Term Investments		Long-Term Investments		Cash and Cash Equivalents		Short-Term Investments		Long-Term Investments
Measured at fair value:
Available-for-sale securities
Money market funds	$	522	$	—	$	—	$	500	$	—	$	—
Corporate obligations	97		390		—		123		217		—
U.S. Government agency and Treasury securities	365		1,952		—		787		1,985		—
Trading securities
Mutual funds	—		—		185		—		—		179
Total	984		2,342		185		1,410		2,202		179

Other measurement basis:
Equity-method investments	—		—		27		—		—		24
Cost-method investments	—		—		12		—		—		13
Cash on hand	215		—		—		217		—		—
Total	$	1,199	$	2,342	$	224	$	1,627	$	2,202	$	216

Aggregate maturities of investments in debt securities classified as available-for-sale

The following table presents the aggregate maturities of investments in debt securities classified as available for sale at December 31, 2014:



Due	Fair Value
One year or less	$	3,121
One to two years	205

Assets and liabilities accounted for at fair value



	Fair Value December 31, 2014		Level 1		Level 2
Assets:
Money market funds	$	522	$	522	$	—
Corporate obligations	487		—		487
U.S. Government agency and Treasury securities	2,317		1,762		555
Mutual funds	185		185		—
Total assets	$	3,511	$	2,469	$	1,042

Liabilities:
Deferred compensation	$	202	$	202	$	—
Total liabilities	$	202	$	202	$	—



	Fair Value December 31, 2013		Level 1		Level 2
Assets:
Money market funds	$	500	$	500	$	—
Corporate obligations	340		—		340
U.S. Government agency and Treasury securities	2,772		2,107		665
Mutual funds	179		179		—
Total assets	$	3,791	$	2,786	$	1,005

Liabilities:
Deferred compensation	$	197	$	197	$	—
Total liabilities	$	197	$	197	$	—

- Definition

Tabular disclosure of available-for-sale securities which includes, but is not limited to, changes in the cost basis and fair value, fair value and gross unrealized gain (loss), fair values by type of security, contractual maturity and classification, amortized cost basis, contracts to acquire securities to be accounted for as available-for-sale, debt maturities, transfers to trading, change in net unrealized holding gain (loss) net of tax, continuous unrealized loss position fair value, aggregate losses qualitative disclosures, other than temporary impairment (OTTI) losses or other disclosures related to available for sale securities.

+ References + Details

Goodwill and acquisition-related intangibles (Tables)

12 Months Ended

Dec. 31, 2014

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of goodwill

The following table summarizes goodwill, net, by segment for the years ended December 31, 2014 and 2013.



	Goodwill
Analog	$	4,158
Embedded Processing	172
Other	32
Total	$	4,362

Schedule of acquisition-related intangible assets

The components of acquisition-related intangible assets as of December 31, 2014 and 2013, are as follows:



		December 31, 2014						December 31, 2013
Acquisition-Related Intangibles	Amortization Period (Years)	Gross Carrying Amount		Accumulated Amortization		Net		Gross Carrying Amount		Accumulated Amortization		Net
Developed technology	5 - 10	$	2,135	$	714	$	1,421	$	2,157	$	526	$	1,631
Customer relationships	8	810		330		480		821		239		582
Other intangibles	5	3		2		1		5		3		2
In-process R&D	n/a	—		n/a		—		8		n/a		8
Total		$	2,948	$	1,046	$	1,902	$	2,991	$	768	$	2,223

Estimated amortization of acquisition-related finite lived intangibles for future years

Future estimated amortization of acquisition-related intangibles for the years ended December 31 is as follows:



	Amortization of Acquisition-Related Intangibles
2015	$	319
2016	319
2017	318
2018	318
2019	288
Thereafter	340

Postretirement benefit plans (Tables)

12 Months Ended

Dec. 31, 2014

Compensation and Retirement Disclosure [Abstract]

Schedule of expense related to defined benefit and retiree health care benefit plans

Expense related to defined benefit and retiree health care benefit plans was as follows:



	U.S. Defined Benefit									U.S. Retiree Health Care									Non-U.S. Defined Benefit
	2014			2013			2012			2014			2013			2012			2014			2013			2012
Service cost	$	21		$	26		$	24		$	4		$	5		$	5		$	39		$	41		$	45
Interest cost	45			45			44			22			20			25			68			61			75
Expected return on plan assets	(42		)	(48		)	(50		)	(20		)	(24		)	(23		)	(80		)	(67		)	(78		)
Amortization of prior service cost (credit)	—			1			1			4			4			3			(2		)	(3		)	(4		)
Recognized net actuarial loss	26			21			16			7			11			13			24			31			41
Net periodic benefit costs	50			45			35			17			16			23			49			63			79

Settlement losses (a) (b)	5			41			—			—			—			—			1			4			193
Curtailment gain	—			—			—			—			—			(1		)	(2		)	(7		)	—
Special termination benefit gains (b)	—			—			(1		)	—			—			—			—			—			(337		)
Total, including other postretirement losses (gains)	$	55		$	86		$	34		$	17		$	16		$	22		$	48		$	60		$	(65	)

(a) Includes non-restructuring and restructuring-related settlement losses.

Schedule of changes in the benefit obligations and plan assets for the defined benefit and retiree health care benefit plans

Changes in the benefit obligations and plan assets for the defined benefit and retiree health care benefit plans were as follows:



	U.S. Defined Benefit						U.S. Retiree Health Care						Non-U.S. Defined Benefit
	2014			2013			2014			2013			2014			2013
Change in plan benefit obligation:
Benefit obligation at beginning of year	$	955		$	1,098		$	472		$	509		$	2,276		$	2,414
Service cost	21			26			4			5			39			41
Interest cost	45			45			22			20			68			61
Participant contributions	—			—			19			18			5			1
Benefits paid	(66		)	(9		)	(45		)	(47		)	(84		)	(81		)
Medicare subsidy	—			—			4			3			—			—
Actuarial loss (gain)	133			(27		)	37			(36		)	275			96
Settlements	(12		)	(178		)	—			—			(7		)	(30		)
Curtailments	—			—			—			—			(11		)	(28		)
Effects of exchange rate changes	—			—			—			—			(245		)	(237		)
Other	—			—			—			—			—			39
Benefit obligation at end of year (BO)	$	1,076		$	955		$	513		$	472		$	2,316		$	2,276

Change in plan assets:
Fair value of plan assets at beginning of year	$	941		$	1,071		$	485		$	517		$	2,179		$	2,218
Actual return on plan assets	132			1			24			41			295			201
Employer contributions (funding of qualified plans)	75			43			10			—			64			62
Employer contributions (payments for non-qualified plans)	12			13			—			—			—			—
Participant contributions	—			—			19			18			5			1
Benefits paid	(66		)	(9		)	(45		)	(45		)	(84		)	(81		)
Medicare subsidy	—			—			4			—			—			—
Settlements	(12		)	(178		)	—			—			(7		)	(30		)
Effects of exchange rate changes	—			—			—			—			(239		)	(232		)
Other	—			—			—			(46		)	—			40
Fair value of plan assets at end of year (FVPA)	$	1,082		$	941		$	497		$	485		$	2,213		$	2,179

Funded status (FVPA – BO) at end of year	$	6		$	(14	)	$	(16	)	$	13		$	(103	)	$	(97	)

Schedule of amounts recognized in balance sheet

Amounts recognized on the Consolidated Balance Sheets as of December 31, 2014, were as follows:



	U.S. Defined Benefit			U.S. Retiree Health Care			Non-U.S. Defined Benefit			Total
Overfunded retirement plans	$	72		$	—		$	55		$	127
Accrued expenses and other liabilities	(9		)	—			(6		)	(15		)
Underfunded retirement plans	(57		)	(16		)	(152		)	(225		)
Funded status (FVPA – BO) at end of year	$	6		$	(16	)	$	(103	)	$	(113	)

Amounts recognized on the Consolidated Balance Sheets as of December 31, 2013, were as follows:



	U.S. Defined Benefit			U.S. Retiree Health Care			Non-U.S. Defined Benefit			Total
Overfunded retirement plans	$	44		$	16		$	70		$	130
Accrued expenses and other liabilities	(7		)	—			(5		)	(12		)
Underfunded retirement plans	(51		)	(3		)	(162		)	(216		)
Funded status (FVPA – BO) at end of year	$	(14	)	$	13		$	(97	)	$	(98	)

Schedule of amounts recognized in other comprehensive income (loss)

The amounts recorded in AOCI for the years ended December 31, 2014 and 2013, are detailed below by plan type:



	U.S. Defined Benefit						U.S. Retiree Health Care						Non-U.S. Defined Benefit						Total
	Net Actuarial Loss			Prior Service Credit			Net Actuarial Loss			Prior Service Cost			Net Actuarial Loss			Prior Service Credit			Net Actuarial Loss			Prior Service Credit
AOCI balance, net of taxes, December 31, 2013	$	149		$	(2	)	$	71		$	10		$	305		$	(9	)	$	525		$	(1	)
Changes in AOCI by category
Adjustments	37			—			29			—			5			1			71			1
Recognized within Net income	(31		)	3			(7		)	(3		)	(25		)	—			(63		)	—
Tax effect	(2		)	(1		)	(8		)	1			6			—			(4		)	—
Total change to AOCI	4			2			14			(2		)	(14		)	1			4			1
AOCI balance, net of taxes, December 31, 2014	$	153		$	—		$	85		$	8		$	291		$	(8	)	$	529		$	—

Schedule of allocation of plan assets

Weighted average asset allocations as of December 31, are as follows:



	U.S. Defined Benefit		U.S. Retiree Health Care		Non-U.S. Defined Benefit
Asset Category	2014	2013	2014	2013	2014	2013
Fixed income securities and cash equivalents	65%	65%	49%	49%	73%	70%
Equity securities	35%	35%	51%	51%	27%	30%

The table below shows target allocation ranges for the plans that hold a substantial majority of the defined benefit assets.



Asset Category	U.S. Defined Benefit	U.S. Retiree Health Care	Non-U.S. Defined Benefit
Fixed income securities and cash equivalents	65%	50%	60% - 100%
Equity securities	35%	50%	0% - 40%

The tables below set forth the fair value of our plan assets as of December 31, 2014 and 2013, using the same three-level hierarchy of fair-value inputs described in Note 9.



	Fair Value December 31, 2014		Level 1		Level 2		Level 3
Assets of U.S. defined benefit plan
Fixed income securities and cash equivalents	$	707	$	—	$	707	$	—
Equity securities	375		—		375		—
Other	—		—		—		—
Total	$	1,082	$	—	$	1,082	$	—

Assets of U.S. retiree health care plan
Fixed income securities and cash equivalents	$	243	$	200	$	43	$	—
Equity securities	254		—		254		—
Total	$	497	$	200	$	297	$	—

Assets of non-U.S. defined benefit plans
Fixed income securities and cash equivalents	$	1,608	$	430	$	1,178	$	—
Equity securities	600		6		594		—
Other	5		—		—		5
Total	$	2,213	$	436	$	1,772	$	5



	Fair Value December 31, 2013		Level 1		Level 2		Level 3
Assets of U.S. defined benefit plan
Fixed income securities and cash equivalents	$	607	$	—	$	607	$	—
Equity securities	297		—		297		—
Other	37		—		—		37
Total	$	941	$	—	$	904	$	37

Assets of U.S. retiree health care plan
Fixed income securities and cash equivalents	$	238	$	193	$	45	$	—
Equity securities	247		—		247		—
Total	$	485	$	193	$	292	$	—

Assets of non-U.S. defined benefit plans
Fixed income securities and cash equivalents	$	1,521	$	397	$	1,124	$	—
Equity securities	650		6		644		—
Other	8		—		—		8
Total	$	2,179	$	403	$	1,768	$	8

Schedule of effect of significant unobservable inputs, changes in plan assets

The following table summarizes the change in the fair values for Level 3 plan assets for the years ending December 31, 2014 and 2013:



	Level 3 Plan Assets
	U.S. Defined Benefit			Non-U.S. Defined Benefit
Balance, December 31, 2012	$	37		$	19
Redemptions	—			(10		)
Unrealized loss	—			(1		)
Balance, December 31, 2013	37			8
Redemptions and sales	(45		)	(2		)
Unrealized gain (loss)	8			(1		)
Balance, December 31, 2014	$	—		$	5

Schedule of assumptions used

Assumptions and investment policies



	Defined Benefit		U.S. Retiree Health Care
	2014	2013	2014	2013
Weighted average assumptions used to determine benefit obligations:
U.S. discount rate	4.23%	5.11%	4.07%	4.83%
Non-U.S. discount rate	2.34%	3.01%

U.S. average long-term pay progression	3.30%	3.50%
Non-U.S. average long-term pay progression	3.27%	3.11%

Weighted average assumptions used to determine net periodic benefit cost:
U.S. discount rate	5.11%	4.59%	4.83%	3.94%
Non-U.S. discount rate	3.01%	2.74%

U.S. long-term rate of return on plan assets	5.25%	5.25%	4.50%	4.75%
Non-U.S. long-term rate of return on plan assets	3.75%	3.34%

U.S. average long-term pay progression	3.50%	3.60%
Non-U.S. average long-term pay progression	3.11%	3.01%

Schedule of expected benefit payments



	U.S. Defined Benefit		U.S. Retiree Health Care		Medicare Subsidy			Non-U.S. Defined Benefit
2015	$	217	$	36	$	(4	)	$	76
2016	95		37		(4		)	78
2017	91		39		(4		)	82
2018	93		40		(5		)	85
2019	93		40		(5		)	89
2020 - 2024	435		194		(9		)	501

Schedule of effect of one-percentage-point change in assumed health care cost trend rates

Assumed health care cost trend rates for the U.S. retiree health care benefit plan at December 31 are as follows:



	2014	2013
Assumed health care cost trend rate for next year	7.0%	7.0%
Ultimate trend rate	5.0%	5.0%
Year in which ultimate trend rate is reached	2023	2022

Debt and lines of credit (Tables)

12 Months Ended

Dec. 31, 2014

Debt Disclosure [Abstract]

Schedule of long-term debt Instruments

Long-term debt outstanding as of December 31, 2014 and 2013 is as follows:



	December 31,
	2014			2013
Notes due 2014 at 1.375%	$	—		$	1,000
Notes due 2015 at 3.95% (assumed with National acquisition)	250			250
Notes due 2015 at 0.45%	750			750
Notes due 2016 at 2.375%	1,000			1,000
Notes due 2017 at 6.60% (assumed with National acquisition)	375			375
Notes due 2017 at 0.875%	250			—
Notes due 2018 at 1.00%	500			500
Notes due 2019 at 1.65%	750			750
Notes due 2021 at 2.75%	250			—
Notes due 2023 at 2.25%	500			500
	4,625			5,125
Net unamortized premium	17			33
Current portion of long-term debt	(1,001		)	(1,000		)
Long-term debt	$	3,641		$	4,158

- Definition

Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 470
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6479336&loc=d3e64711-112823

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(e),(f))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 55
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=34725769&loc=d3e28878-108400

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21538-112644

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28541-108399

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28551-108399

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21521-112644

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 22
-Article 5

+ Details

Commitments and contingencies (Tables)

12 Months Ended

Dec. 31, 2014

Commitments and Contingencies Disclosure [Abstract]

Minimum payments under non-cancellable operating leases capitalized software licenses and purchase commitments

As of December 31, 2014, we had committed to make the following minimum payments under our non-cancellable operating leases, capitalized software licenses and purchase commitments:



	Operating Leases		Capitalized Software Licenses		Purchase Commitments
2015	$	87	$	39	$	96
2016	66		27		52
2017	45		—		35
2018	33		—		14
2019	21		—		10
Thereafter	80		—		2

Supplemental financial information (Tables)

12 Months Ended

Dec. 31, 2014

Supplemental Financial Information [Abstract]

Other income (expense), net

Other Income (Expense), Net



	For Years Ended December 31,
	2014		2013			2012
Interest income	$	7	$	10		$	8
Tax interest income (expense)	6		(10		)	32
Net gains on investments	5		18			18
Other (a)	3		(1		)	(11		)
Total	$	21	$	17		$	47

Prepaid expenses and other current assets

Prepaid Expenses and Other Current Assets



	December 31,
	2014		2013
Prepaid taxes on intercompany inventory profits	$	693	$	667
Other prepaid expenses and current assets	157		196
Total	$	850	$	863

Property, plant and equipment at cost

Property, Plant and Equipment at Cost



	Depreciable Lives (Years)	December 31,
	Depreciable Lives (Years)	2014		2013
Land	n/a	$	137	$	175
Buildings and improvements	5 - 40	2,801		2,913
Machinery and equipment	3 - 10	3,328		3,468
Total		$	6,266	$	6,556

Accrued expenses and other liabilities

Accrued Expenses and Other Liabilities



	December 31,
	2014		2013
Customer incentive programs and allowances	$	101	$	143
Severance and related expenses	60		158
Other	337		350
Total	$	498	$	651

Accumulated other comprehensive income (loss), net of taxes

Accumulated Other Comprehensive Income (Loss), Net of Taxes



	December 31,
	2014			2013
Postretirement benefit plans:
Net actuarial loss	$	(529	)	$	(525	)
Prior service credit	—			1
Cash flow hedge derivative	(3		)	(4		)
Total	$	(532	)	$	(528	)

Amounts reclassified out of AOCI to Net income, net of taxes

The table below details where on the Consolidated Statements of Income these transactions are recorded.



	For Years Ended December 31,						Impact to Related Statement of Income Line
Details about AOCI Components	2014			2013			Impact to Related Statement of Income Line
Net actuarial gains (losses) of defined benefit plans:
Recognized net actuarial loss and Settlement losses (a)	$	63		$	108		Increase to Pension expense (b)
Tax effect	(21		)	(37		)	Decrease to Provision for income taxes
Recognized within Net income, net of taxes	$	42		$	71		Decrease to Net income

Prior service cost of defined benefit plans:
Amortization of prior service cost (credit) and Curtailment gain (a)	$	—		$	(5	)	Decrease to Pension expense (b)
Tax effect	—			2			Increase to Provision for income taxes
Recognized within Net income, net of taxes	$	—		$	(3	)	Increase to Net income

Derivative instruments:
Amortization of treasury rate locks	$	2		$	2		Increase to Interest and debt expense
Tax effect	(1		)	(1		)	Decrease to Provision for income taxes
Recognized within Net income, net of taxes	$	1		$	1		Decrease to Net income

(a) Detailed in Note 11.

(b) Pension expense is included in COR, R&D, SG&A and Restructuring charges/other in the Consolidated Statements of Income.

Quarterly financial data (unaudited) (Tables)

12 Months Ended

Dec. 31, 2014

Quarterly Financial Information Disclosure [Abstract]

Schedule of quarterly financial data



	Quarter
2014	1st			2nd			3rd			4th
Revenue	$	2,983		$	3,292		$	3,501		$	3,269
Gross profit	1,607			1,881			2,044			1,895
Included in Operating profit:
Acquisition charges	83			82			83			82
Restructuring charges/other	(11		)	(4		)	(9		)	(27		)
Operating profit	690			982			1,175			1,100
Net income	487			683			826			825

Earnings per common share:
Basic earnings per common share	$	0.44		$	0.63		$	0.77		$	0.78
Diluted earnings per common share	0.44			0.62			0.76			0.76

	Quarter
2013	1st			2nd			3rd			4th
Revenue	$	2,885		$	3,047		$	3,244		$	3,028
Gross profit	1,374			1,570			1,779			1,640
Included in Operating profit:
Acquisition charges	86			86			86			84
Restructuring charges/other	15			(282		)	16			62
Operating profit	395			906			844			687
Net income	362			660			629			511

Earnings per common share:
Basic earnings per common share	$	0.32		$	0.59		$	0.56		$	0.46
Diluted earnings per common share	0.32			0.58			0.56			0.46

Description of business, including segment and geographic area information (Details)
$ in Millions

3 Months Ended

12 Months Ended

Dec. 31, 2014

USD ($)

Sep. 30, 2014

USD ($)

Jun. 30, 2014

USD ($)

Mar. 31, 2014

USD ($)

Dec. 31, 2013

USD ($)

Sep. 30, 2013

USD ($)

Jun. 30, 2013

USD ($)

Mar. 31, 2013

USD ($)

Dec. 31, 2014

USD ($)

Reportable_Segments

Dec. 31, 2013

USD ($)

Dec. 31, 2012

USD ($)

Segment Reporting Information [Line Items]

Number of reportable segments | Reportable_Segments

Revenue

$ 3,269

$ 3,501

$ 3,292

$ 2,983

$ 3,028

$ 3,244

$ 3,047

$ 2,885

$ 13,045

$ 12,205

$ 12,825

Operating profit

1,100

$ 1,175

$ 982

$ 690

687

$ 844

$ 906

$ 395

3,947

2,832

1,973

Property, plant and equipment, net

2,840

3,399

2,840

3,399

3,912

Analog

Segment Reporting Information [Line Items]

Revenue

8,104

7,194

6,998

Operating profit

2,786

1,859

1,650

Embedded Processing

Segment Reporting Information [Line Items]

Revenue

2,740

2,450

2,257

Operating profit

384

185

158

Other

Segment Reporting Information [Line Items]

Revenue

2,201

2,561

3,570

Operating profit

777

788

165

United States

Segment Reporting Information [Line Items]

Revenue

1,625

1,666

1,596

Property, plant and equipment, net

1,436

1,765

1,436

1,765

1,931

Asia

Segment Reporting Information [Line Items]

Revenue

^[1]

7,915

7,370

7,808

Property, plant and equipment, net

1,096

1,277

1,096

1,277

1,547

Europe

Segment Reporting Information [Line Items]

Revenue

2,293

1,926

1,861

Property, plant and equipment, net

162

196

162

196

241

Japan

Segment Reporting Information [Line Items]

Revenue

1,032

1,072

1,357

Property, plant and equipment, net

124

144

124

144

174

Rest of world

Segment Reporting Information [Line Items]

Revenue

180

171

203

Property, plant and equipment, net

$ 22

$ 17

China (including Hong Kong)

Segment Reporting Information [Line Items]

Revenue

$ 5,700

$ 5,200

$ 5,400

[1]	Revenue from products shipped into China, including Hong Kong, was $5.7 billion in 2014, $5.2 billion in 2013 and $5.4 billion in 2012.

Basis of presentation and significant accounting policies and practices (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Percent of revenue from sales to distributors	60.00%
Percent of distributor revenue from sales of consigned inventory	60.00%
Advertising expense	$ 45	$ 46	$ 46
Maximum length to maturity of a security, from the investment date, where it is classified as cash and cash equivalent	90 days
Length to maturity from the investment date of a security where the length of time is too short to be classified as a short-term investment	90 days
Consigned inventory	$ 258	$ 202

Basis of presentation and significant accounting policies and practices - Earnings per share (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended								12 Months Ended
	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Basic EPS:
Net income	$ 825	$ 826	$ 683	$ 487	$ 511	$ 629	$ 660	$ 362	$ 2,821	$ 2,162	$ 1,759
Income allocated to RSUs									(44)	(37)	(31)
Income allocated to common stock for basic EPS calculation									$ 2,777	$ 2,125	$ 1,728
Weighted average number of shares outstanding, basic (in shares)									1,065,000,000	1,098,000,000	1,132,000,000
Basic earnings per common share	$ 0.78	$ 0.77	$ 0.63	$ 0.44	$ 0.46	$ 0.56	$ 0.59	$ 0.32	$ 2.61	$ 1.94	$ 1.53
Adjustment for dilutive shares:
Stock-based compensation plans (in shares)									15,000,000	15,000,000	14,000,000
Diluted EPS:
Net income	$ 825	$ 826	$ 683	$ 487	$ 511	$ 629	$ 660	$ 362	$ 2,821	$ 2,162	$ 1,759
Income allocated to RSUs									(43)	(36)	(31)
Income allocated to common stock for diluted EPS calculation									$ 2,778	$ 2,126	$ 1,728
Weighted average number of shares outstanding, diluted (in shares)									1,080,000,000	1,113,000,000	1,146,000,000
Diluted earnings per common share	$ 0.76	$ 0.76	$ 0.62	$ 0.44	$ 0.46	$ 0.56	$ 0.58	$ 0.32	$ 2.57	$ 1.91	$ 1.51
Antidilutive securities excluded from computation of earnings per share, Amount (in shares)									11,000,000	0	52,000,000

Acquisition charges (Details) $ in Millions	3 Months Ended								12 Months Ended			48 Months Ended
Acquisition charges (Details) $ in Millions	Dec. 31, 2014 USD ($)	Sep. 30, 2014 USD ($)	Jun. 30, 2014 USD ($)	Mar. 31, 2014 USD ($)	Dec. 31, 2013 USD ($)	Sep. 30, 2013 USD ($)	Jun. 30, 2013 USD ($)	Mar. 31, 2013 USD ($)	Dec. 31, 2014 USD ($)	Dec. 31, 2013 USD ($)	Dec. 31, 2012 USD ($) positions	Dec. 31, 2014 USD ($)
Business Combination, Separately Recognized Transactions [Line Items]
Acquisition charges	$ 82	$ 83	$ 82	$ 83	$ 84	$ 86	$ 86	$ 86	$ 330	$ 341	$ 450
National Semiconductor
Business Combination, Separately Recognized Transactions [Line Items]
Acquisition-related charges									330	341	$ 471
Number of jobs eliminated (in jobs) \| positions											350
National Semiconductor \| Amortization of intangible assets
Business Combination, Separately Recognized Transactions [Line Items]
Acquisition charges									319	323	$ 325
National Semiconductor \| Stock-based compensation
Business Combination, Separately Recognized Transactions [Line Items]
Acquisition charges									11	11	17
National Semiconductor \| Retention bonuses
Business Combination, Separately Recognized Transactions [Line Items]
Acquisition charges									0	7	57
National Semiconductor \| Severance and other benefits
Business Combination, Separately Recognized Transactions [Line Items]
Acquisition charges									0	0	16
National Semiconductor \| Transaction and other costs
Business Combination, Separately Recognized Transactions [Line Items]
Acquisition charges									0	0	35
National Semiconductor \| As recorded in Acquisition charges
Business Combination, Separately Recognized Transactions [Line Items]
Acquisition charges									330	341	450
National Semiconductor \| As recorded in COR
Business Combination, Separately Recognized Transactions [Line Items]
Acquisition-related charges									$ 0	$ 0	$ 21
National Semiconductor \| Acquisition Costs, Severance and other benefits
Business Combination, Separately Recognized Transactions [Line Items]
Acquisition charges												$ 86
Payments against cumulative charges related to National												84
National Semiconductor \| Acquisition Costs, Severance and other benefits, Change of control
Business Combination, Separately Recognized Transactions [Line Items]
Payments against cumulative charges related to National												$ 41

Restructuring charges/other (Details)

12 Months Ended

15 Months Ended

24 Months Ended

26 Months Ended

36 Months Ended

Dec. 31, 2014

USD ($)

Dec. 31, 2013

USD ($)

Dec. 31, 2012

USD ($)

facilities

Dec. 31, 2014

USD ($)

Jobs

Dec. 31, 2013

USD ($)

Dec. 31, 2014

USD ($)

Dec. 31, 2014

USD ($)

Restructuring and Related Cost [Line Items]

Restructuring charges

^[1]

$ 20,000,000

$ 126,000,000

$ 400,000,000

Payments for severance costs

124,000,000

292,000,000

46,000,000

Goodwill impairment loss

90,000,000

Gains on sales of assets

75,000,000

Gain on technology transfer

315,000,000

Gain on transfer of Japan substitutional pension

144,000,000

Semiconductor manufacturing facilities in Hiji, Japan, and Houston, Texas

Restructuring and Related Cost [Line Items]

Gains on sales of assets

17,000,000

Semiconductor manufacturing facility in Nice, France

Restructuring and Related Cost [Line Items]

Gains on sales of assets

30,000,000

Real estate in Santa Clara, California

Restructuring and Related Cost [Line Items]

Gains on sales of assets

28,000,000

2013 Actions

Restructuring and Related Cost [Line Items]

Expected number of positions eliminated | Jobs

1,100

Restructuring charges

26,000,000

49,000,000

$ 75,000,000

Prior Actions

Restructuring and Related Cost [Line Items]

Restructuring charges

(6,000,000)

77,000,000

$ 400,000,000

Prior Actions | Semiconductor manufacturing facilities in Hiji, Japan, and Houston, Texas

Restructuring and Related Cost [Line Items]

Restructuring charges

$ 200,000,000

Restructuring and related activities, Number of facilities closing | facilities

Former Reporting Segment Wireless | Prior Actions

Restructuring and Related Cost [Line Items]

Restructuring charges

$ 383,000,000

Goodwill impairment loss

90,000,000

Employee Severance And Benefits Charges Reserves Member | 2013 Actions

Restructuring and Related Cost [Line Items]

Restructuring charges

^[1]

16,000,000

49,000,000

$ 0

Payments for severance costs

43,000,000

$ 43,000,000

Employee Severance And Benefits Charges Reserves Member | Prior Actions

Restructuring and Related Cost [Line Items]

Restructuring charges

^[1]

(6,000,000)

36,000,000

251,000,000

Payments for severance costs

$ 73,000,000

$ 266,000,000

$ 23,000,000

Employee Severance And Benefits Charges Reserves Member | Prior Actions | Semiconductor manufacturing facilities in Hiji, Japan, and Houston, Texas

Restructuring and Related Cost [Line Items]

Payments for severance costs

$ 103,000,000

Employee Severance And Benefits Charges Reserves Member | Former Reporting Segment Wireless | Prior Actions

Restructuring and Related Cost [Line Items]

Payments for severance costs

$ 247,000,000

[1]	Includes changes in estimates.

Restructuring charges/other - Components of restructuring charges (Details) - USD ($)
$ in Millions

3 Months Ended

12 Months Ended

15 Months Ended

Dec. 31, 2014

Sep. 30, 2014

Jun. 30, 2014

Mar. 31, 2014

Dec. 31, 2013

Sep. 30, 2013

Jun. 30, 2013

Mar. 31, 2013

Dec. 31, 2014

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2014

Restructuring Cost and Reserve [Line Items]

Restructuring charges

^[1]

$ 20

$ 126

$ 400

Gains on sales of assets

(75)

Gain on technology transfer

(315)

Gain on transfer of Japan substitutional pension

(144)

Other

Restructuring charges/other

$ (27)

$ (9)

$ (4)

$ (11)

$ 62

$ 16

$ (282)

$ 15

(51)

(189)

264

2013 Actions

Restructuring Cost and Reserve [Line Items]

Severance and benefits cost

^[2]

Other exit costs

Restructuring charges

$ 75

Prior Actions

Restructuring Cost and Reserve [Line Items]

Severance and benefits cost

^[2]

(6)

251

Other exit costs

^[2]

(1)

128

Accelerated depreciation

Restructuring charges

$ (6)

$ 77

$ 400

[1]	Includes changes in estimates.
[2]	Includes changes in estimates.

Restructuring charges/other - Restructuring reserve (Details) - USD ($)

12 Months Ended

15 Months Ended

Dec. 31, 2014

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2014

Restructuring Reserve [Roll Forward]

Beginning accrual

$ 161,000,000

$ 349,000,000

$ 116,000,000

Restructuring charges

^[1]

20,000,000

126,000,000

400,000,000

Non-cash items

^[2]

(22,000,000)

(121,000,000)

Payments

(124,000,000)

(292,000,000)

(46,000,000)

Remaining accrual

57,000,000

161,000,000

349,000,000

$ 57,000,000

2013 Actions

Restructuring Reserve [Roll Forward]

Restructuring charges

26,000,000

49,000,000

75,000,000

Prior Actions

Restructuring Reserve [Roll Forward]

Restructuring charges

(6,000,000)

77,000,000

400,000,000

Severance and benefits cost | 2013 Actions

Restructuring Reserve [Roll Forward]

Beginning accrual

49,000,000

Restructuring charges

^[1]

16,000,000

49,000,000

Non-cash items

^[2]

Payments

(43,000,000)

Remaining accrual

22,000,000

49,000,000

22,000,000

Severance and benefits cost | Prior Actions

Restructuring Reserve [Roll Forward]

Beginning accrual

105,000,000

340,000,000

109,000,000

Restructuring charges

^[1]

(6,000,000)

36,000,000

251,000,000

Non-cash items

^[2]

(5,000,000)

3,000,000

Payments

(73,000,000)

(266,000,000)

(23,000,000)

Remaining accrual

26,000,000

105,000,000

340,000,000

26,000,000

Other Charges | 2013 Actions

Restructuring Reserve [Roll Forward]

Beginning accrual

Restructuring charges

^[1]

10,000,000

Non-cash items

^[2]

Payments

(1,000,000)

Remaining accrual

9,000,000

Other Charges | Prior Actions

Restructuring Reserve [Roll Forward]

Beginning accrual

7,000,000

9,000,000

7,000,000

Restructuring charges

^[1]

41,000,000

149,000,000

Non-cash items

^[2]

(17,000,000)

(124,000,000)

Payments

(7,000,000)

(26,000,000)

(23,000,000)

Remaining accrual

$ 0

$ 7,000,000

$ 9,000,000

$ 0

[1]	Includes changes in estimates.
[2]	Reflects charges for goodwill impairment, stock-based compensation, impacts of postretirement benefit plans and accelerated depreciation.

Stock-based compensation (Details) - USD ($) $ / shares in Units, $ in Millions		12 Months Ended
	Jan. 02, 2015	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Future compensation cost not yet recognized in the Statements of Income		$ 308
Future compensation costs to be recognized in 2015		168
Future compensation costs to be recognized in 2016		91
Future compensation costs to be recognized in 2017		44
Future compensation costs to be recognized in 2018		5
Remaining stock repurchase authorizations		$ 3,170
Employee Stock Option
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Award vesting period (in years)		4 years
Look back period to determine option life used in Black Scholes Merton pricing model		10 years
Restricted Stock Units (RSUs)
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Award vesting period (in years)		4 years
Long-term incentive and director compensation plans \| Employee Stock Option
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Long-term incentive and director compensation plans option pricing (in percent)		100.00%
Term of the long term incentive stock options		10 years
Award vesting period (in years)		4 years
Aggregate intrinsic value of options exercised		$ 367	$ 427	$ 244
Future compensation cost not yet recognized in the Statements of Income		$ 113
Weighted-average exercise price, Exercised (in dollars per share)		$ 27.75
Outstanding options exercisable (in shares)		27,601,866
Long-term incentive and director compensation plans \| Restricted Stock Units (RSUs)
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Award vesting period (in years)		4 years
Long-term incentive plan RSU conversion to common stock feature		Each RSU represents the right to receive one share of TI common stock on the vesting date
Weighted-average grant-date fair value, Granted (in dollars per share)		$ 44.71	$ 33.70	$ 31.60
Total fair value of shares vested from RSU lapses		$ 133	$ 98	$ 120
Future compensation cost not yet recognized in the Statements of Income		$ 195
TI employees 2005 stock purchase plan
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Percent of the underlying common stock's market price participants pay for options (in hundredths)		85.00%
Employee stock purchase plan option term (in months)		3 months
Aggregate intrinsic value of options exercised		$ 12	$ 13	$ 13
Weighted-average exercise price, Exercised (in dollars per share)		$ 39.44
Outstanding options exercisable (in shares)		0
Weighted average grant date fair value of options granted (dollars per share)		$ 7.34	$ 5.71	$ 4.52
Subsequent Event \| TI employees 2005 stock purchase plan
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Weighted-average exercise price, Exercised (in dollars per share)	$ 45.46
Annual Vesting \| Employee Stock Option
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Non-qualified stock options award vesting rights		25.00%

Stock-based compensation - Expense (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation expense	$ 277	$ 287	$ 263
COR
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation expense	48	49	48
R&D
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation expense	62	67	71
SG&A
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation expense	156	160	127
Acquisition charges
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation expense	$ 11	$ 11	$ 17

Stock-based compensation - Fair-value methods and assumptions (Details) - $ / shares	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Fair value assumptions method used for non-qualified stock options	Black-Scholes-Merton option-pricing model
Weighted average grant date fair value, per share (in dollars per share)	$ 8.13	$ 6.78	$ 8.31
Expected volatility (in percent)	22.00%	26.00%	30.00%
Expected lives	7 years 3 months 18 days	7 years 4 months 24 days	7 years 1 month 6 days
Risk-free interest rates (in percent)	2.45%	1.43%	1.40%
Expected dividend yields (in percent)	2.72%	2.56%	2.10%

Stock-based compensation - Stock options and RSUs outstanding (Details) - $ / shares	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Employee Stock Option
Stock Options, Shares
Exercised (in shares)	(19,503,382)	(45,507,711)	(22,409,816)
Employee Stock Option \| Long-term incentive and director compensation plans
Stock Options, Shares
Options outstanding, Beginning balance (in shares)	64,930,540
Granted (in shares)	14,053,185
Forfeited and expired (in shares)	(1,832,897)
Exercised (in shares)	(19,503,382)
Options outstanding, Ending balance (in shares)	57,647,446	64,930,540
Stock Options, Weighted Average Exercise Price per Share
Weighted-average exercise price, Outstanding, Beginning of period (in dollars per share)	$ 28.98
Weighted-average exercise price, Granted (in dollars per share)	44.11
Weighted-average exercise price, Expired and forfeited (in dollars per share)	36.54
Weighted-average exercise price, Exercised (in dollars per share)	27.75
Weighted-average exercise price, Outstanding, End of period (in dollars per share)	$ 32.84	$ 28.98
Restricted Stock Units (RSUs)
Restricted Stock Units, Shares
Vested RSUs (in shares)	(5,609,627)	(5,741,981)	(4,182,928)
Restricted Stock Units (RSUs) \| Long-term incentive and director compensation plans
Restricted Stock Units, Shares
Awards outstanding other than options, Beginning balance (in shares)	20,892,022
Granted (in shares)	3,184,237
Vested RSUs (in shares)	(5,609,627)
Expired and forfeited (in shares)	(1,162,817)
Awards outstanding other than options, Ending balance (in shares)	17,303,815	20,892,022
Sharebased Compensation Arrangementby Sharebased Payment Award Non Option Equity Instruments Outstanding Weighted Average Exercise Price Roll Forward
Weighted-average grant date fair value, Beginning of period (in dollars per share)	$ 29.94
Weighted-average grant-date fair value, Granted (in dollars per share)	44.71	$ 33.70	$ 31.60
Weighted-average grant date fair value, Vested RSUs (in dollars per share)	23.68
Weighted-average grant date fair value, Expired and forfeited (in dollars per share)	33.22
Weighted-average grant date fair value, Ending of period (in dollars per share)	$ 34.47	$ 29.94

Stock-based compensation - Range of exercise prices (Details) - Employee Stock Option - Long-term incentive and director compensation plans - $ / shares	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Range of Exercise Price, Minimum	$ 14.47
Range of Exercise Price, Maximum	$ 55.41
Number Outstanding (Shares)	57,647,446	64,930,540
Weighted Average Remaining Contractual Life (Years)	6 years 4 months 24 days
Options Outstanding Weighted Average Exercise Price per Share	$ 32.84	$ 28.98
Number Exercisable (Shares)	27,601,866
Options Exercisable Weighted Average Exercise Price per Share	$ 27.34
Range Of Exercise Prices $14.47 to $20.00
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Range of Exercise Price, Minimum	14.47
Range of Exercise Price, Maximum	$ 20.00
Number Outstanding (Shares)	4,061,577
Weighted Average Remaining Contractual Life (Years)	4 years
Options Outstanding Weighted Average Exercise Price per Share	$ 14.98
Number Exercisable (Shares)	4,061,577
Options Exercisable Weighted Average Exercise Price per Share	$ 14.98
Range Of Exercise Prices $20.01 to $30.00
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Range of Exercise Price, Minimum	20.01
Range of Exercise Price, Maximum	$ 30.00
Number Outstanding (Shares)	11,270,125
Weighted Average Remaining Contractual Life (Years)	3 years 8 months 12 days
Options Outstanding Weighted Average Exercise Price per Share	$ 25.47
Number Exercisable (Shares)	11,250,200
Options Exercisable Weighted Average Exercise Price per Share	$ 25.46
Range Of Exercise Prices $30.01 to $40.00
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Range of Exercise Price, Minimum	30.01
Range of Exercise Price, Maximum	$ 40.00
Number Outstanding (Shares)	28,910,636
Weighted Average Remaining Contractual Life (Years)	6 years 6 months
Options Outstanding Weighted Average Exercise Price per Share	$ 33.00
Number Exercisable (Shares)	12,288,339
Options Exercisable Weighted Average Exercise Price per Share	$ 33.14
Range Of Exercise Prices $40.01 to $50.00
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Range of Exercise Price, Minimum	40.01
Range of Exercise Price, Maximum	$ 50.00
Number Outstanding (Shares)	13,399,020
Weighted Average Remaining Contractual Life (Years)	9 years 1 month 6 days
Options Outstanding Weighted Average Exercise Price per Share	$ 44.10
Number Exercisable (Shares)	1,750
Options Exercisable Weighted Average Exercise Price per Share	$ 42.66
Range Of Exercise Prices $50.01 to $55.41
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Range of Exercise Price, Minimum	50.01
Range of Exercise Price, Maximum	$ 55.41
Number Outstanding (Shares)	6,088
Weighted Average Remaining Contractual Life (Years)	9 years 10 months 24 days
Options Outstanding Weighted Average Exercise Price per Share	$ 55.41
Number Exercisable (Shares)	0

Stock-based compensation - Options vested and expected to vest (Details) - Long-term incentive and director compensation plans - Employee Stock Option
$ / shares in Units, $ in Millions

12 Months Ended

Dec. 31, 2014

USD ($)

$ / shares

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Number of outstanding shares, vested and expected to vest (in shares) | shares

56,328,323

^[1]

Weighted-average remaining contractual life, vested and expected to vest (in years)

6 years 3 months 18 days

^[1]

Weighted-average exercise price per share, vested and expected to vest (in dollars per share) | $ / shares

$ 32.69

^[1]

Intrinsic value, vested and expected to vest (millions of dollars) | $

$ 1,170

^[1]

Outstanding options exercisable (in shares) | shares

27,601,866

Weighted-average remaining contractual life, options exercisable

4 years 4 months 24 days

Weighted-average exercise price per share, options exercisable (in dollars per share) | $ / shares

$ 27.34

Intrinsic value, options exercisable (millions of dollars) | $

$ 721

Expected forfeitures, effects of which are included (in shares) | shares

1,000,000

Aggregate intrinsic value of stock options outstanding, excluding the effects of expected forfeitures | $

$ 1,189

[1]	Includes effects of expected forfeitures of approximately 1 million shares. Excluding the effects of expected forfeitures, the aggregate intrinsic value of stock options outstanding was $1,189 million.

Stock-based compensation - Director deferred compensation (Details) - Director - shares	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Beginning balance, Directors deferred compensation account (in shares)	129,264
New shares deferred (in shares)	13,636
Issued (in shares)	(7,178)	(12,909)	(6,592)
Ending balance, Directors deferred compensation account (in shares)	135,722	129,264

Stock-based compensation - Employee stock purchase plan (Details) - TI employees 2005 stock purchase plan	12 Months Ended
	Dec. 31, 2014 $ / shares shares
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Options outstanding, Beginning balance (in shares) \| shares	485,408
Granted (in shares) \| shares	1,673,479
Exercised (in shares) \| shares	(1,784,184)
Options outstanding, Ending balance (in shares) \| shares	374,703
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]
Weighted-average exercise price, Outstanding, Beginning of period (in dollars per share) \| $ / shares	$ 36.64
Weighted-average exercise price, Granted (in dollars per share) \| $ / shares	41.60
Weighted-average exercise price, Exercised (in dollars per share) \| $ / shares	39.44
Weighted-average exercise price, Outstanding, End of period (in dollars per share) \| $ / shares	$ 45.46

Stock-based compensation - Effect on shares outstanding and treasury shares (Details) - shares

12 Months Ended

Dec. 31, 2014

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Schedule of Changes in Treasury Stock [Line Items]

Treasury stock (in shares)

694,189,127

658,012,970

632,636,970

601,131,631

Repurchases

61,665,209

77,564,013

59,757,780

Total issued (in shares)

(25,481,874)

(52,175,104)

(28,245,849)

Director

Schedule of Changes in Treasury Stock [Line Items]

Issued (in shares)

(7,178)

(12,909)

(6,592)

Employee Stock Option

Schedule of Changes in Treasury Stock [Line Items]

Exercised (in shares)

(19,503,382)

(45,507,711)

(22,409,816)

Previously unissued common shares (in shares)

^[1]

180,955

Stock applied to taxes

Total issued (in shares)

(21,280,948)

(47,894,545)

(25,058,359)

Stock applied to exercises or taxes

6,618

Employee Stock Option | Director

Schedule of Changes in Treasury Stock [Line Items]

Issued (in shares)

Restricted Stock Units (RSUs)

Schedule of Changes in Treasury Stock [Line Items]

Vested RSUs (in shares)

(5,609,627)

(5,741,981)

(4,182,928)

Previously unissued common shares (in shares)

^[1]

4,593

Stock applied to taxes

1,461,422

990,845

Total issued (in shares)

(4,200,926)

(4,280,559)

(3,187,490)

Stock applied to exercises or taxes

1,408,701

Restricted Stock Units (RSUs) | Director

Schedule of Changes in Treasury Stock [Line Items]

Issued (in shares)

TI employees 2005 stock purchase plan

Schedule of Changes in Treasury Stock [Line Items]

Exercised (in shares)

(1,784,184)

TI employees 2005 stock purchase plan | Employee Stock Option

Schedule of Changes in Treasury Stock [Line Items]

Exercised (in shares)

(1,784,184)

(2,386,834)

(2,829,498)

TI employees 2005 stock purchase plan | Restricted Stock Units (RSUs)

Schedule of Changes in Treasury Stock [Line Items]

Vested RSUs (in shares)

[1]	Beginning in 2013, only treasury shares were issued.

Stock-based compensation - Shares available for future grants and reserve for issuance (Details) - shares

Dec. 31, 2014

Dec. 31, 2013

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Reserved for issuance (in shares)

^[1]

160,692,694

Shares to be issued upon exercise of outstanding options and RSUs

^[1]

(75,461,686)

Available for future grants

85,231,008

Long-term incentive and director compensation plans

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Reserved for issuance (in shares)

^[1]

121,127,656

Shares to be issued upon exercise of outstanding options and RSUs

^[1]

(75,086,983)

Available for future grants

46,040,673

TI employees 2005 stock purchase plan

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Reserved for issuance (in shares)

^[1]

39,565,038

Shares to be issued upon exercise of outstanding options and RSUs

^[1]

(374,703)

Available for future grants

39,190,335

Director

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Directors deferred compensation account (in shares)

135,722

129,264

[1]	Includes 135,722 shares credited to directors’ deferred stock accounts that settle in shares of TI common stock. These shares are not included as grants outstanding at December 31, 2014.

Stock-based compensation - Effects on cash flows (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Proceeds from common stock transactions	$ 616	$ 1,314	$ 523
Tax benefit realized from stock options exercised	$ 218	$ 227	$ 133

Profit sharing plans (Details) - USD ($) $ in Millions	12 Months Ended
Profit sharing plans (Details) - USD ($) $ in Millions	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Profit sharing plans [Abstract]
Minimum percentage amount of operating margin the company must attain for full calendar year for any profit sharing per individual to be paid (in hundredths)	10.00%
Amount of gross compensation eligible for profit sharing deferral per individual in calendar year when minimum operating margin is attained by company (in hundredths)	2.00%
Maximum amount of gross compensation eligible for profit sharing per individual in calendar year when 35% operating margin is attained by company (in hundredths)	20.00%
Percentage of operating margin the company must attain for full calendar year for maximum amount of profit sharing per individual to be paid (in hundredths)	35.00%
Profit sharing expense	$ 269	$ 161	$ 96

Income taxes (Details) - USD ($) $ in Millions	12 Months Ended
Income taxes (Details) - USD ($) $ in Millions	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Income Tax Contingency [Line Items]
Discrete tax benefits related to reinstatement of the U.S. R&D tax credit		$ 79
Discrete tax benefits related to U.S. benefit for manufacturing			$ 252
Deferred tax asset, change in amount related to unutilized tax credits	$ 24
Tax loss carryforward, U.S. and non-U.S.	108
Tax loss carryforward, U.S. and non-U.S., set to expire	0
Amount of undistributed foreign earnings	7,670
Cash payments for income taxes	1,104	569	171
Amount of deferred tax assets possibly to be realized	56	76
Unrecognized tax benefits	108	91	184	$ 210
Audit Assessments Not Made
Income Tax Contingency [Line Items]
Unrecognized tax benefits	76
Change in Accounting Method Accounted for as Change in Estimate
Income Tax Contingency [Line Items]
Amount of unrecorded changes in unrecognized tax benefits	52
Audit Assessments
Income Tax Contingency [Line Items]
Unrecognized tax benefits	32
Increase Liability for Transfer Pricing Issues
Income Tax Contingency [Line Items]
Amount of unrecorded changes in unrecognized tax benefits	29
Settlement with Taxing Authority
Income Tax Contingency [Line Items]
Amount of unrecorded changes in unrecognized tax benefits	29
Foreign Tax Authority
Income Tax Contingency [Line Items]
Benefits from tax holidays	$ 44	$ 40	$ 51
Tax holiday, review time period	5 years

Income taxes - Income before income taxes (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Income Tax Disclosure [Abstract]
Income before income taxes - U.S.	$ 2,684	$ 1,507	$ 319
Income before income taxes - Non-U.S.	1,190	1,247	1,616
Income before income taxes	$ 3,874	$ 2,754	$ 1,935

Income taxes - Provision (benefit) for income taxes (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Income Tax Disclosure [Abstract]
U.S. Federal - Current	$ 911	$ 291	$ (108)
Non-U.S. - Current	194	247	156
U.S. State - Current	9	4	(2)
Total current income tax expense (benefit)	1,114	542	46
U.S. Federal - Deferred	(73)	17	65
Non-U.S. - Deferred	11	33	65
U.S. State - Deferred	1	0	0
Total deferred income tax expense (benefit)	(61)	50	130
Total U.S. Federal income taxes	838	308	(43)
Total Non-U.S. income taxes	205	280	221
Total U.S. State income taxes	10	4	(2)
Provision for income taxes	$ 1,053	$ 592	$ 176

Income taxes - Reconciliation items from income tax computed at statutory federal rate (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Income Tax Disclosure [Abstract]
Computed tax at statutory rate	$ 1,356	$ 964	$ 677
Non-U.S. effective tax rates	(212)	(156)	(345)
U.S. R&D tax credit	(59)	(129)	0
U.S. tax benefit for manufacturing	(51)	(66)	(158)
Impact of changes to uncertain tax positions	3	(14)	(88)
Non-deductible expenses	6	13	42
Other	10	(20)	48
Provision for income taxes	$ 1,053	$ 592	$ 176

Income taxes - Components of deferred income tax assets and liabilities (Details) - USD ($) $ in Millions	Dec. 31, 2014	Dec. 31, 2013
Deferred income tax assets:
Deferred loss and tax credit carryforwards	$ 289	$ 345
Accrued expenses	248	265
Stock-based compensation	238	262
Inventories and related reserves	157	162
Retirement costs for defined benefit and retiree health care	96	101
Other	122	148
Deferred income tax assets, gross	1,150	1,283
Valuation allowance	(195)	(219)
Deferred income tax assets, net	955	1,064
Deferred income tax liabilities:
Acquisition-related intangibles and fair-value adjustments	(688)	(804)
International earnings	(104)	(121)
Property, plant and equipment	(10)	(57)
Other	(37)	(31)
Deferred income tax liabilities, net	(839)	(1,013)
Net deferred income tax asset	$ 116	$ 51

Income taxes - Deferred income tax assets and liabilities (Details) - USD ($) $ in Millions	Dec. 31, 2014	Dec. 31, 2013
Income Tax Disclosure [Abstract]
Current deferred income tax assets	$ 347	$ 393
Noncurrent deferred income tax assets	172	207
Current deferred income tax liabilities	(4)	(1)
Noncurrent deferred income tax liabilities	(399)	(548)
Net deferred income tax asset	$ 116	$ 51

Income taxes - Uncertain tax positions (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]
Balance, January 1	$ 91	$ 184	$ 210
Additions based on tax positions related to the current year	10	7	12
Additions for tax positions of prior years	52	19	45
Reductions for tax positions of prior years	(9)	(10)	(92)
Settlements with tax authorities	(36)	(96)	39
Expiration of the statute of limitations for assessing taxes	0	(13)	(30)
Balance, December 31	108	91	184
Interest income (expense) recognized in the year ended December 31	6	(10)	32
Interest receivable (payable) as of December 31	$ 0	$ (5)	$ 8

Financial instruments and risk concentration (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Allowance for doubtful accounts, current
Accounts receivable allowances [Roll Forward]
Balance at beginning of year	$ 22	$ 31	$ 19
Additions charged (credited) to operating results	(9)	(9)	12
Recoveries and write-offs, net	(1)	0	0
Balance at end of year	12	$ 22	$ 31
Foreign Exchange Forward
Valuation and Qualifying Accounts Disclosure [Line Items]
Notional value of forward foreign currency exchange contracts	504
Foreign Exchange Forward \| Japanese Yen
Valuation and Qualifying Accounts Disclosure [Line Items]
Notional value of forward foreign currency exchange contracts	183
Foreign Exchange Forward \| Euros
Valuation and Qualifying Accounts Disclosure [Line Items]
Notional value of forward foreign currency exchange contracts	163
Foreign Exchange Forward \| British Pound
Valuation and Qualifying Accounts Disclosure [Line Items]
Notional value of forward foreign currency exchange contracts	$ 29

Valuation of debt and equity investments and certain liabilities - Investments at fair value (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and Cash Equivalents	$ 1,199	$ 1,627
Short-Term Investments	2,342	2,202
Long-Term Investments	224	216
Proceeds from sales, redemptions and maturities of short-term available-for-sale securities	2,966	4,249	$ 2,198
Aggregate maturities of investments in money market funds and other debt securities classified as available for sale [Abstract]
One year or less	3,121
One to two years	205
Other-than-temporary declines and impairments in investments recognized in other income and expense		5	$ 7
Estimate of Fair Value Measurement
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and Cash Equivalents	984	1,410
Short-Term Investments	2,342	2,202
Long-Term Investments	185	179
Estimate of Fair Value Measurement \| Available-for-sale Securities \| Money market funds
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and Cash Equivalents	522	500
Short-Term Investments	0	0
Long-Term Investments	0	0
Estimate of Fair Value Measurement \| Available-for-sale Securities \| Corporate obligations
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and Cash Equivalents	97	123
Short-Term Investments	390	217
Long-Term Investments	0	0
Estimate of Fair Value Measurement \| Available-for-sale Securities \| U.S. Government agency and Treasury securities
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and Cash Equivalents	365	787
Short-Term Investments	1,952	1,985
Long-Term Investments	0	0
Estimate of Fair Value Measurement \| Trading Securities \| Mutual funds
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and Cash Equivalents	0	0
Short-Term Investments	0	0
Long-Term Investments	185	179
Portion at Other than Fair Value Measurement \| Equity-method investments
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and Cash Equivalents	0	0
Short-Term Investments	0	0
Long-Term Investments	27	24
Portion at Other than Fair Value Measurement \| Cost-method investments
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and Cash Equivalents	0	0
Short-Term Investments	0	0
Long-Term Investments	12	13
Portion at Other than Fair Value Measurement \| Cash on hand
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and Cash Equivalents	215	217
Short-Term Investments	0	0
Long-Term Investments	$ 0	$ 0

Valuation of debt and equity investments and certain liabilities - Fair value assets and liabilities measured on recurring basis (Details) - Fair Value, Measurements, Recurring - USD ($)	Dec. 31, 2014	Dec. 31, 2013
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets fair value	$ 3,511,000,000	$ 3,791,000,000
Total liabilities fair value	202,000,000	197,000,000
Deferred compensation
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total liabilities fair value	202,000,000	197,000,000
Money market funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets fair value	522,000,000	500,000,000
Corporate obligations
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets fair value	487,000,000	340,000,000
U.S. Government agency and Treasury securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets fair value	2,317,000,000	2,772,000,000
Mutual funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets fair value	185,000,000	179,000,000
Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets fair value	2,469,000,000	2,786,000,000
Total liabilities fair value	202,000,000	197,000,000
Level 1 \| Deferred compensation
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total liabilities fair value	202,000,000	197,000,000
Level 1 \| Money market funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets fair value	522,000,000	500,000,000
Level 1 \| Corporate obligations
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets fair value	0	0
Level 1 \| U.S. Government agency and Treasury securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets fair value	1,762,000,000	2,107,000,000
Level 1 \| Mutual funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets fair value	185,000,000	179,000,000
Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets fair value	1,042,000,000	1,005,000,000
Total liabilities fair value	0	0
Level 2 \| Deferred compensation
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total liabilities fair value	0	0
Level 2 \| Money market funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets fair value	0	0
Level 2 \| Corporate obligations
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets fair value	487,000,000	340,000,000
Level 2 \| U.S. Government agency and Treasury securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets fair value	555,000,000	665,000,000
Level 2 \| Mutual funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets fair value	0	0
Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets fair value	0	0
Total liabilities fair value	$ 0	$ 0

Goodwill and acquisition-related intangibles - Goodwill (Details) - USD ($)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Goodwill [Line Items]
Goodwill, net	$ 4,362,000,000	$ 4,362,000,000
Goodwill impairment loss	0	0	$ 90,000,000
Accumulated impairment of goodwill	90,000,000	90,000,000
Analog
Goodwill [Line Items]
Goodwill, net	4,158,000,000	4,158,000,000
Embedded Processing
Goodwill [Line Items]
Goodwill, net	172,000,000	172,000,000
Other
Goodwill [Line Items]
Goodwill, net	$ 32,000,000	$ 32,000,000

Goodwill and acquisition-related intangibles - Acquisition-related intangibles (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Finite-Lived Intangible Assets, Net [Abstract]
Acquisition-related intangibles, gross carrying amount	$ 2,948	$ 2,991
Acquisition-related intangibles, accumulated amortization	1,046	768
Acquisition-related intangibles, net	1,902	2,223
Amortization of acquisition-related intangibles	321	336	$ 342
Finite-Lived Intangible Assets, Future Amortization Expense [Abstract]
2015	319
2016	319
2017	318
2018	318
2019	288
Thereafter	340
Developed technology
Finite-Lived Intangible Assets, Net [Abstract]
Acquisition-related intangibles, gross carrying amount	2,135	2,157
Acquisition-related intangibles, accumulated amortization	714	526
Acquisition-related intangibles, net	$ 1,421	1,631
Customer relationships
Finite-Lived Intangible Assets, Net [Abstract]
Acquisition-related intangibles, amortization period	8 years
Acquisition-related intangibles, gross carrying amount	$ 810	821
Acquisition-related intangibles, accumulated amortization	330	239
Acquisition-related intangibles, net	$ 480	582
Other intangibles
Finite-Lived Intangible Assets, Net [Abstract]
Acquisition-related intangibles, amortization period	5 years
Acquisition-related intangibles, gross carrying amount	$ 3	5
Acquisition-related intangibles, accumulated amortization	2	3
Acquisition-related intangibles, net	1	2
In-process R&D
Finite-Lived Intangible Assets, Net [Abstract]
Acquisition-related intangibles, gross carrying amount	0	8
Acquisition-related intangibles, net	$ 0	$ 8
Minimum \| Developed technology
Finite-Lived Intangible Assets, Net [Abstract]
Acquisition-related intangibles, amortization period	5 years
Maximum \| Developed technology
Finite-Lived Intangible Assets, Net [Abstract]
Acquisition-related intangibles, amortization period	10 years

Postretirement benefit plans (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Description of employer contributions to the U.S. retirement plans	Both defined contribution plans offer an employer-matching savings option that allows employees to make pre-tax contributions to various investment choices, including a TI common stock fund. Employees who elected to continue accruing a benefit in the qualified defined benefit pension plans may also participate in the defined contribution plan, where employer-matching contributions are provided for up to 2 percent of the employee’s annual eligible earnings. Employees who elected not to continue accruing a benefit in the defined benefit pension plans, and employees hired after November 1997 and through December 31, 2003, may participate in the enhanced defined contribution plan. This plan provides for a fixed employer contribution of 2 percent of the employee’s annual eligible earnings, plus an employer-matching contribution of up to 4 percent of the employee’s annual eligible earnings. Employees hired after December 31, 2003, do not receive the fixed employer contribution of 2 percent of the employee’s annual eligible earnings.
Number of company shares held by the U.S. defined contribution plans at year-end (in shares)	14,000,000	15,000,000
Value of the company shares held by the U.S. defined contribution plans at year-end	$ 740	$ 678
Dividends paid on the company shares held by the U.S. defined contribution plans at year-end	19	18
Aggregate expense for the U.S. defined contribution plans	$ 60	62	$ 70
Defined benefit pension plan formula, highest consecutive years of compensation (in years)	5 years
Value of the company shares held by the non-U.S. retirement plans at year-end	$ 17	15
Length of time certain gains and losses are considered when determining the market-related value of assets related to the U.S. Qualified pension and retiree health care plans (in years)	3 years
Expected contribution to retirement benefit plans in next fiscal year	$ 100
Defined benefit plan assets directly invested in TI common stock	0
Liability to participants of the deferred compensation plan	$ 202
Deferred compensation plan assets	185
U.S. defined benefit plan
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Accumulated benefit obligation	968	882
Future amortization of net actuarial loss	19
Future amortization of unrecognized prior service cost (credit)	0
U.S. retiree health care plan
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Future amortization of net actuarial loss	9
Future amortization of unrecognized prior service cost (credit)	6
Effect of a one-percentage point change in assumed health care cost trend rates [Abstract]
Effect of a one percentage point increase on accumulated postretirement benefit obligation (in hundredths)	27
Effect of a one percentage point decrease on accumulated postretirement benefit obligation (in hundredths)	22
Effect of a one percentage point increase on service and interest cost components (in hundredths)	1
Effect of a one percentage point increase on service and interest cost components (in hundredths)	1
Non-U.S. defined benefit plan
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Accumulated benefit obligation	2,150	$ 2,120
Future amortization of net actuarial loss	22
Future amortization of unrecognized prior service cost (credit)	$ (2)
Defined contribution plan, also still accruing defined benefits
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Defined contribution plan, employer matching contribution (percent)	2.00%
Enhanced defined contribution plan
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Defined contribution plan, employer matching contribution (percent)	4.00%
Defined contribution plan, employer fixed contribution (percent)	2.00%
Defined contribution plan
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Defined contribution plan, employer matching contribution (percent)	4.00%

Postretirement benefit plans - Defined benefit plans (Details) - USD ($)
$ in Millions

3 Months Ended

12 Months Ended

Dec. 31, 2014

Sep. 30, 2014

Jun. 30, 2014

Mar. 31, 2014

Dec. 31, 2013

Sep. 30, 2013

Jun. 30, 2013

Mar. 31, 2013

Sep. 30, 2012

Dec. 31, 2014

Dec. 31, 2013

Dec. 31, 2012

Defined Benefit Plan Disclosure [Line Items]

Restructuring charges/other

$ (27)

$ (9)

$ (4)

$ (11)

$ 62

$ 16

$ (282)

$ 15

$ (51)

$ (189)

$ 264

U.S. defined benefit plan

Defined Benefit Plan Disclosure [Line Items]

Service cost

Interest cost

Expected return on plan assets

(42)

(48)

(50)

Amortization of prior service cost (credit)

Recognized net actuarial loss

Net periodic benefit costs

Settlement losses

^[1],[2]

Curtailment gain

Special termination benefit gains

^[2]

(1)

Total, including other postretirement losses (gains)

Fair value of benefit obligation

1,076

955

1,076

955

1,098

Fair value of plan assets

1,082

941

1,082

941

1,071

U.S. retiree health care plan

Defined Benefit Plan Disclosure [Line Items]

Service cost

Interest cost

Expected return on plan assets

(20)

(24)

(23)

Amortization of prior service cost (credit)

Recognized net actuarial loss

Net periodic benefit costs

Settlement losses

^[1],[2]

Curtailment gain

(1)

Special termination benefit gains

^[2]

Total, including other postretirement losses (gains)

Fair value of benefit obligation

513

472

513

472

509

Fair value of plan assets

497

485

497

485

517

Non-U.S. defined benefit plan

Defined Benefit Plan Disclosure [Line Items]

Service cost

Interest cost

Expected return on plan assets

(80)

(67)

(78)

Amortization of prior service cost (credit)

(2)

(3)

(4)

Recognized net actuarial loss

Net periodic benefit costs

Settlement losses

^[1],[2]

193

Curtailment gain

(2)

(7)

Special termination benefit gains

^[2]

(337)

Total, including other postretirement losses (gains)

(65)

Restructuring charges/other

$ (144)

Fair value of benefit obligation

2,316

2,276

2,316

2,276

2,414

Fair value of plan assets

$ 2,213

$ 2,179

$ 2,213

$ 2,179

$ 2,218

Non-U.S. defined benefit plan | Difference Between Fair Values of the Obligations Settled and Assets Transferred

Defined Benefit Plan Disclosure [Line Items]

Restructuring charges/other

(337)

Non-U.S. defined benefit plan | Obligation and Assets Transferred to Japan Subsitutional Pension

Defined Benefit Plan Disclosure [Line Items]

Fair value of benefit obligation

533

Fair value of plan assets

196

Non-U.S. defined benefit plan | Offset By Settlement Loss Related to Recognition of Previously Unrecognized Actuarial Losses Included In Accumulated Other Comprehensive Income

Defined Benefit Plan Disclosure [Line Items]

Restructuring charges/other

$ 193

[1]

Includes non-restructuring and restructuring-related settlement losses.

[2]

Transfer of Japan substitutional pension in 2012: In Japan, we maintain employee pension fund plans (EPFs) pursuant to the Japanese Welfare Pension Insurance Law (JWPIL). An EPF consists of two portions: a substitutional portion based on JWPIL-determined minimum old-age pension benefits similar to Social Security benefits in the United States and a corporate portion established at the discretion of each employer. Employers and employees are exempt from contributing to the Japanese Pension Insurance (JPI) if the substitutional portion is funded by an EPF.The JWPIL was amended to permit each EPF to separate the substitutional portion and transfer those obligations and related assets to the government of Japan. After such a transfer, the employer is required to contribute periodically to JPI, and the government of Japan is responsible for future benefit payments relating to the substitutional portion.During the third quarter of 2012, our EPF received final approval for such a separation and transferred the obligations and assets of its substitutional portion to the government of Japan. On a pre-tax basis, this resulted in a net gain of $144 million recorded in Restructuring charges/other on our Consolidated Statements of Income and included in Other, as shown in Note 4. This net gain of $144 million consisted of two parts - a gain of $337 million, representing the difference between the fair values of the obligations settled of $533 million and the assets transferred from the pension trust to the government of Japan of $196 million, offset by a settlement loss of $193 million related to the recognition of previously unrecognized actuarial losses included in AOCI.

Postretirement benefit plans - Benefit obligations and plan assets (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]
Funded status (FVPA – BO) at end of year	$ (113)	$ (98)
U.S. defined benefit plan
Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]
Benefit obligation at beginning of year	955	1,098
Service cost	21	26	$ 24
Interest cost	45	45	44
Participant contributions	0	0
Benefits paid	(66)	(9)
Medicare subsidy	0	0
Actuarial loss (gain)	133	(27)
Settlements	(12)	(178)
Curtailments	0	0
Effects of exchange rate changes	0	0
Other	0	0
Benefit obligation at end of year (BO)	1,076	955	1,098
Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]
Fair value of plan assets at beginning of year	941	1,071
Actual return on plan assets	132	1
Employer contributions (funding of qualified plans)	75	43
Employer contributions (payments for non-qualified plans)	12	13
Participant contributions	0	0
Benefits paid	(66)	(9)
Medicare subsidy	0	0
Settlements	(12)	(178)
Effects of exchange rate changes	0	0
Other	0	0
Fair value of plan assets at end of year (FVPA)	1,082	941	1,071
Funded status (FVPA – BO) at end of year	6	(14)
U.S. retiree health care plan
Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]
Benefit obligation at beginning of year	472	509
Service cost	4	5	5
Interest cost	22	20	25
Participant contributions	19	18
Benefits paid	(45)	(47)
Medicare subsidy	4	3
Actuarial loss (gain)	37	(36)
Settlements	0	0
Curtailments	0	0
Effects of exchange rate changes	0	0
Other	0	0
Benefit obligation at end of year (BO)	513	472	509
Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]
Fair value of plan assets at beginning of year	485	517
Actual return on plan assets	24	41
Employer contributions (funding of qualified plans)	10	0
Employer contributions (payments for non-qualified plans)	0	0
Participant contributions	19	18
Benefits paid	(45)	(45)
Medicare subsidy	4	0
Settlements	0	0
Effects of exchange rate changes	0	0
Other	0	(46)
Fair value of plan assets at end of year (FVPA)	497	485	517
Funded status (FVPA – BO) at end of year	(16)	13
Non-U.S. defined benefit plan
Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]
Benefit obligation at beginning of year	2,276	2,414
Service cost	39	41	45
Interest cost	68	61	75
Participant contributions	5	1
Benefits paid	(84)	(81)
Medicare subsidy	0	0
Actuarial loss (gain)	275	96
Settlements	(7)	(30)
Curtailments	(11)	(28)
Effects of exchange rate changes	(245)	(237)
Other	0	39
Benefit obligation at end of year (BO)	2,316	2,276	2,414
Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]
Fair value of plan assets at beginning of year	2,179	2,218
Actual return on plan assets	295	201
Employer contributions (funding of qualified plans)	64	62
Employer contributions (payments for non-qualified plans)	0	0
Participant contributions	5	1
Benefits paid	(84)	(81)
Medicare subsidy	0	0
Settlements	(7)	(30)
Effects of exchange rate changes	(239)	(232)
Other	0	40
Fair value of plan assets at end of year (FVPA)	2,213	2,179	$ 2,218
Funded status (FVPA – BO) at end of year	$ (103)	$ (97)

Postretirement benefit plans - Amounts recognized on the balance sheet (Details) - USD ($) $ in Millions	Dec. 31, 2014	Dec. 31, 2013
Defined Benefit Plan Disclosure [Line Items]
Overfunded retirement plans	$ 127	$ 130
Accrued expenses and other liabilities	(15)	(12)
Underfunded retirement plans	(225)	(216)
Funded status (FVPA – BO) at end of year	(113)	(98)
U.S. defined benefit plan
Defined Benefit Plan Disclosure [Line Items]
Overfunded retirement plans	72	44
Accrued expenses and other liabilities	(9)	(7)
Underfunded retirement plans	(57)	(51)
Funded status (FVPA – BO) at end of year	6	(14)
U.S. retiree health care plan
Defined Benefit Plan Disclosure [Line Items]
Overfunded retirement plans	0	16
Accrued expenses and other liabilities	0	0
Underfunded retirement plans	(16)	(3)
Funded status (FVPA – BO) at end of year	(16)	13
Non-U.S. defined benefit plan
Defined Benefit Plan Disclosure [Line Items]
Overfunded retirement plans	55	70
Accrued expenses and other liabilities	(6)	(5)
Underfunded retirement plans	(152)	(162)
Funded status (FVPA – BO) at end of year	$ (103)	$ (97)

Postretirement benefit plans - Amounts recognized in AOCI (Details) $ in Millions	12 Months Ended
	Dec. 31, 2014 USD ($)
Defined Benefit Plan Amounts Recognized In Other Comprehensive Income Roll Forward
AOCI balance, net actuarial loss portion (net of taxes), beginning of period	$ 525
Adjustments, net actuarial loss	71
Recognized within Net income, net actuarial loss	(63)
Tax effect, net actuarial loss	(4)
Total change to AOCI, net actuarial loss	4
AOCI balance, net actuarial loss portion (net of taxes), period end	529
Defined Benefit Plan Amounts Recognized In Other comprehensive Income Prior Service Cost (Credit) Portion [Roll Forward]
AOCI balance, net prior service cost (credit) (net of taxes), beginning of period	(1)
Adjustments, prior service cost (credit)	1
Recognized within Net income, prior service cost (credit)	0
Tax effect, prior service cost (credit)	0
Total change to AOCI, prior service cost	1
AOCI balance, net prior service cost (credit) (net of taxes), period end	0
U.S. defined benefit plan
Defined Benefit Plan Amounts Recognized In Other Comprehensive Income Roll Forward
AOCI balance, net actuarial loss portion (net of taxes), beginning of period	149
Adjustments, net actuarial loss	37
Recognized within Net income, net actuarial loss	(31)
Tax effect, net actuarial loss	(2)
Total change to AOCI, net actuarial loss	4
AOCI balance, net actuarial loss portion (net of taxes), period end	153
Defined Benefit Plan Amounts Recognized In Other comprehensive Income Prior Service Cost (Credit) Portion [Roll Forward]
AOCI balance, net prior service cost (credit) (net of taxes), beginning of period	(2)
Adjustments, prior service cost (credit)	0
Recognized within Net income, prior service cost (credit)	3
Tax effect, prior service cost (credit)	(1)
Total change to AOCI, prior service cost	2
AOCI balance, net prior service cost (credit) (net of taxes), period end	0
U.S. retiree health care plan
Defined Benefit Plan Amounts Recognized In Other Comprehensive Income Roll Forward
AOCI balance, net actuarial loss portion (net of taxes), beginning of period	71
Adjustments, net actuarial loss	29
Recognized within Net income, net actuarial loss	(7)
Tax effect, net actuarial loss	(8)
Total change to AOCI, net actuarial loss	14
AOCI balance, net actuarial loss portion (net of taxes), period end	85
Defined Benefit Plan Amounts Recognized In Other comprehensive Income Prior Service Cost (Credit) Portion [Roll Forward]
AOCI balance, net prior service cost (credit) (net of taxes), beginning of period	10
Adjustments, prior service cost (credit)	0
Recognized within Net income, prior service cost (credit)	(3)
Tax effect, prior service cost (credit)	1
Total change to AOCI, prior service cost	(2)
AOCI balance, net prior service cost (credit) (net of taxes), period end	8
Non-U.S. defined benefit plan
Defined Benefit Plan Amounts Recognized In Other Comprehensive Income Roll Forward
AOCI balance, net actuarial loss portion (net of taxes), beginning of period	305
Adjustments, net actuarial loss	5
Recognized within Net income, net actuarial loss	(25)
Tax effect, net actuarial loss	6
Total change to AOCI, net actuarial loss	(14)
AOCI balance, net actuarial loss portion (net of taxes), period end	291
Defined Benefit Plan Amounts Recognized In Other comprehensive Income Prior Service Cost (Credit) Portion [Roll Forward]
AOCI balance, net prior service cost (credit) (net of taxes), beginning of period	(9)
Adjustments, prior service cost (credit)	1
Recognized within Net income, prior service cost (credit)	0
Tax effect, prior service cost (credit)	0
Total change to AOCI, prior service cost	1
AOCI balance, net prior service cost (credit) (net of taxes), period end	$ (8)

Postretirement benefit plans - Changes in fair values for Level 3 (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
U.S. defined benefit plan
Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]
Fair value of plan assets at beginning of year	$ 941	$ 1,071
Fair value of plan assets at end of year (FVPA)	1,082	941
U.S. defined benefit plan \| Level 3
Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]
Fair value of plan assets at beginning of year	37	37
Redemptions and sales	(45)	0
Unrealized gain (loss)	8	0
Fair value of plan assets at end of year (FVPA)	0	37
Non-U.S. defined benefit plan
Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]
Fair value of plan assets at beginning of year	2,179	2,218
Fair value of plan assets at end of year (FVPA)	2,213	2,179
Non-U.S. defined benefit plan \| Level 3
Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]
Fair value of plan assets at beginning of year	8	19
Redemptions and sales	(2)	(10)
Unrealized gain (loss)	(1)	(1)
Fair value of plan assets at end of year (FVPA)	$ 5	$ 8

Postretirement benefit plans - Weighted average assumptions used (Details)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
U.S. defined benefit plan
Weighted average assumptions used to determine benefit obligations [Abstract]
Discount rate (in percents)	4.23%	5.11%
Long-term pay progression (in percents)	3.30%	3.50%
Weighted average assumptions used to determine net periodic benefit cost [Abstract]
Discount rate (in percents)	5.11%	4.59%
Long term rate of return on plan assets (in percents)	5.25%	5.25%
Long-term pay progression (in percents)	3.50%	3.60%
U.S. retiree health care plan
Weighted average assumptions used to determine benefit obligations [Abstract]
Discount rate (in percents)	4.07%	4.83%
Weighted average assumptions used to determine net periodic benefit cost [Abstract]
Discount rate (in percents)	4.83%	3.94%
Long term rate of return on plan assets (in percents)	4.50%	4.75%
Non-U.S. defined benefit plan
Weighted average assumptions used to determine benefit obligations [Abstract]
Discount rate (in percents)	2.34%	3.01%
Long-term pay progression (in percents)	3.27%	3.11%
Weighted average assumptions used to determine net periodic benefit cost [Abstract]
Discount rate (in percents)	3.01%	2.74%
Long term rate of return on plan assets (in percents)	3.75%	3.34%
Long-term pay progression (in percents)	3.11%	3.01%

Postretirement benefit plans - Weighted average allocations (Details)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
U.S. defined benefit plan \| Fixed income securities and cash equivalents
Defined Benefit Plan Disclosure [Line Items]
Targeted allocation (in percents)	65.00%
Actual plan asset allocation (in percents)	65.00%	65.00%
U.S. defined benefit plan \| Equity securities
Defined Benefit Plan Disclosure [Line Items]
Targeted allocation (in percents)	35.00%
Actual plan asset allocation (in percents)	35.00%	35.00%
U.S. retiree health care plan \| Fixed income securities and cash equivalents
Defined Benefit Plan Disclosure [Line Items]
Targeted allocation (in percents)	50.00%
Actual plan asset allocation (in percents)	49.00%	49.00%
U.S. retiree health care plan \| Equity securities
Defined Benefit Plan Disclosure [Line Items]
Targeted allocation (in percents)	50.00%
Actual plan asset allocation (in percents)	51.00%	51.00%
Non-U.S. defined benefit plan \| Fixed income securities and cash equivalents
Defined Benefit Plan Disclosure [Line Items]
Targeted allocation range minimum (in percents)	60.00%
Targeted allocation range maximum (in percents)	100.00%
Actual plan asset allocation (in percents)	73.00%	70.00%
Non-U.S. defined benefit plan \| Equity securities
Defined Benefit Plan Disclosure [Line Items]
Targeted allocation range minimum (in percents)	0.00%
Targeted allocation range maximum (in percents)	40.00%
Actual plan asset allocation (in percents)	27.00%	30.00%

Postretirement benefit plans - Benefits expected to pay (Details) $ in Millions	Dec. 31, 2014 USD ($)
Defined Benefit Plan Disclosure [Line Items]
2015 Medicare subsidy	$ (4)
2016 Medicare subsidy	(4)
2017 Medicare subsidy	(4)
2018 Medicare subsidy	(5)
2019 Medicare subsidy	(5)
2020 - 2024 Medicare subsidy	(9)
U.S. defined benefit plan
Defined Benefit Plan Disclosure [Line Items]
2015 payment	217
2016 payment	95
2017 payment	91
2018 payment	93
2019 payment	93
2020 - 2024 payment	435
U.S. retiree health care plan
Defined Benefit Plan Disclosure [Line Items]
2015 payment	36
2016 payment	37
2017 payment	39
2018 payment	40
2019 payment	40
2020 - 2024 payment	194
Non-U.S. defined benefit plan
Defined Benefit Plan Disclosure [Line Items]
2015 payment	76
2016 payment	78
2017 payment	82
2018 payment	85
2019 payment	89
2020 - 2024 payment	$ 501

Postretirement benefit plans - Health care cost trend rates (Details) - U.S. retiree health care plan	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Defined Benefit Plan Disclosure [Line Items]
Assumed health care cost trend rate for next year (in percents)	7.00%	7.00%
Ultimate trend rate (in percents)	5.00%	5.00%
Year in which ultimate trend rate is reached	2023	2022

Debt and lines of credit (Details) - USD ($)	1 Months Ended			12 Months Ended
Debt and lines of credit (Details) - USD ($)	Mar. 31, 2014	May 31, 2013	Aug. 31, 2012	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Debt Instrument [Line Items]
Line of credit facility, maximum borrowing capacity through March 2019				$ 2,000,000,000
Commercial paper				0
Long-term debt, gross				4,625,000,000	$ 5,125,000,000
Proceeds from issuance of long-term debt				498,000,000	986,000,000	$ 1,492,000,000
Interest and debt expense				94,000,000	95,000,000	85,000,000
Interest paid				102,000,000	102,000,000	$ 97,000,000
Notes payable
Debt Instrument [Line Items]
Long-term debt, gross	$ 500,000,000	$ 1,000,000,000	$ 1,500,000,000
Payments of debt issuance costs	3,000,000	6,000,000	7,000,000
Proceeds from issuance of long-term debt	498,000,000	986,000,000	1,492,000,000
Repayments of long-term debt				1,000,000,000	1,500,000,000
Notes payable \| Notes due 2017 at 0.875%
Debt Instrument [Line Items]
Long-term debt, gross	250,000,000			250,000,000	0
Notes payable \| Notes due 2021 at 2.75%
Debt Instrument [Line Items]
Long-term debt, gross	$ 250,000,000			250,000,000	0
Notes payable \| Notes due 2018 at 1.00%
Debt Instrument [Line Items]
Long-term debt, gross		500,000,000		500,000,000	500,000,000
Notes payable \| Notes due 2023 at 2.25%
Debt Instrument [Line Items]
Long-term debt, gross		$ 500,000,000		500,000,000	500,000,000
Notes payable \| Notes due 2015 at 0.45%
Debt Instrument [Line Items]
Long-term debt, gross			750,000,000	750,000,000	750,000,000
Notes payable \| Notes due 2019 at 1.65%
Debt Instrument [Line Items]
Long-term debt, gross			$ 750,000,000	$ 750,000,000	$ 750,000,000

Debt and lines of credit - Schedule of long-term debt outstanding (Details) - USD ($) $ in Millions	Dec. 31, 2014	Mar. 31, 2014	Dec. 31, 2013	May 31, 2013	Aug. 31, 2012
Debt Instrument [Line Items]
Long-term debt, gross	$ 4,625		$ 5,125
Net unamortized premium	17		33
Current portion of long-term debt	(1,001)		(1,000)
Long-term debt	3,641		4,158
Notes payable
Debt Instrument [Line Items]
Long-term debt, gross		$ 500		$ 1,000	$ 1,500
Notes payable \| Notes due 2014 at 1.375%
Debt Instrument [Line Items]
Long-term debt, gross	$ 0		$ 1,000
Long-term debt stated interest rate ( in percents)	1.375%		1.375%
Notes payable \| Notes due 2015 at 0.45%
Debt Instrument [Line Items]
Long-term debt, gross	$ 750		$ 750		750
Long-term debt stated interest rate ( in percents)	0.45%		0.45%
Notes payable \| Notes due 2016 at 2.375%
Debt Instrument [Line Items]
Long-term debt, gross	$ 1,000		$ 1,000
Long-term debt stated interest rate ( in percents)	2.375%		2.375%
Notes payable \| Notes due 2017 at 0.875%
Debt Instrument [Line Items]
Long-term debt, gross	$ 250	250	$ 0
Long-term debt stated interest rate ( in percents)	0.875%		0.875%
Notes payable \| Notes due 2018 at 1.00%
Debt Instrument [Line Items]
Long-term debt, gross	$ 500		$ 500	500
Long-term debt stated interest rate ( in percents)	1.00%		1.00%
Notes payable \| Notes due 2019 at 1.65%
Debt Instrument [Line Items]
Long-term debt, gross	$ 750		$ 750		$ 750
Long-term debt stated interest rate ( in percents)	1.65%		1.65%
Notes payable \| Notes due 2021 at 2.75%
Debt Instrument [Line Items]
Long-term debt, gross	$ 250	$ 250	$ 0
Long-term debt stated interest rate ( in percents)	2.75%		2.75%
Notes payable \| Notes due 2023 at 2.25%
Debt Instrument [Line Items]
Long-term debt, gross	$ 500		$ 500	$ 500
Long-term debt stated interest rate ( in percents)	2.25%		2.25%
National Semiconductor \| Notes payable \| Notes due 2015 at 3.95% (assumed with National acquisition)
Debt Instrument [Line Items]
Long-term debt, gross	$ 250		$ 250
Long-term debt stated interest rate ( in percents)	3.95%		3.95%
National Semiconductor \| Notes payable \| Notes due 2017 at 6.60% (assumed with National acquisition)
Debt Instrument [Line Items]
Long-term debt, gross	$ 375		$ 375
Long-term debt stated interest rate ( in percents)	6.60%		6.60%

Commitments and contingencies (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Commitments and Contingencies Disclosure [Abstract]
Rental and lease expense incurred	$ 113	$ 120	$ 124
Standard product warranty description	three years of coverage; an obligation to repair, replace or refund; and a maximum payment obligation tied to the price paid for our products
Standard product warranty coverage (in years)	3 years
Operating Leases
2015	$ 87
2016	66
2017	45
2018	33
2019	21
Thereafter	80
Purchase Commitments
2015	96
2016	52
2017	35
2018	14
2019	10
Thereafter	2
Discontinued operation - indemnification obligation potential exposure	200
Capitalized Software Licenses
Capitalized Software Licenses
2015	39
2016	27
2017	0
2018	0
2019	0
Thereafter	$ 0

Supplemental financial information - Other income (expense), net (Details) - USD ($)
$ in Millions

12 Months Ended

Dec. 31, 2014

Dec. 31, 2013

Dec. 31, 2012

Supplemental Financial Information [Abstract]

Interest income

$ 7

$ 10

$ 8

Tax interest income (expense)

(10)

Net gains on investments

Other

^[1]

(1)

(11)

Total

Lease income

$ 15

Aggregate amount of non-cancellable future lease payments

$ 51

[1]

Includes lease income of approximately $15 million per year, primarily from the purchaser of a former business. As of December 31, 2014, the aggregate amount of non-cancellable future lease payments to be received from these leases is $51 million. These leases contain renewal options. Other also includes miscellaneous non-operational items such as losses related to former businesses, including settlements in 2012; gains and losses from currency exchange rate changes; and gains and losses from our derivative financial instruments, primarily forward foreign currency exchange contracts.

Supplemental financial information - Prepaid expenses and other current assets (Details) - USD ($) $ in Millions	Dec. 31, 2014	Dec. 31, 2013
Supplemental Financial Information [Abstract]
Prepaid taxes on intercompany inventory profits	$ 693	$ 667
Other prepaid expenses and current assets	157	196
Total	$ 850	$ 863

Supplemental financial information - Property, plant and equipment at cost (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Property, Plant and Equipment [Line Items]
Property, plant and equipment at cost	$ 6,266	$ 6,556
Lease income	15	15	$ 15
Land
Property, Plant and Equipment [Line Items]
Property, plant and equipment at cost	137	175
Buildings and improvements
Property, Plant and Equipment [Line Items]
Property, plant and equipment at cost	$ 2,801	2,913
Buildings and improvements \| Minimum
Property, Plant and Equipment [Line Items]
Property, plant and equipment at cost, depreciable lives	5 years
Buildings and improvements \| Maximum
Property, Plant and Equipment [Line Items]
Property, plant and equipment at cost, depreciable lives	40 years
Machinery and equipment
Property, Plant and Equipment [Line Items]
Property, plant and equipment at cost	$ 3,328	$ 3,468
Machinery and equipment \| Minimum
Property, Plant and Equipment [Line Items]
Property, plant and equipment at cost, depreciable lives	3 years
Machinery and equipment \| Maximum
Property, Plant and Equipment [Line Items]
Property, plant and equipment at cost, depreciable lives	10 years

Supplemental financial information - Accrued expenses and other liabilities (Details) - USD ($) $ in Millions	Dec. 31, 2014	Dec. 31, 2013
Supplemental Financial Information [Abstract]
Customer incentive programs and allowances	$ 101	$ 143
Severance and related expenses	60	158
Other	337	350
Total	$ 498	$ 651

Supplemental financial information - Accumulated other comprehensive income (loss), net of taxes (Details) - USD ($) $ in Millions	Dec. 31, 2014	Dec. 31, 2013
Supplemental Financial Information [Abstract]
Net actuarial loss	$ (529)	$ (525)
Prior service credit	0	1
Cash flow hedge derivative	(3)	(4)
Total	$ (532)	$ (528)

- Definition

Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.

+ References + Details

Supplemental financial information - Amounts reclassified out of AOCI (Details) - USD ($)
$ in Millions

3 Months Ended

12 Months Ended

Dec. 31, 2014

Sep. 30, 2014

Jun. 30, 2014

Mar. 31, 2014

Dec. 31, 2013

Sep. 30, 2013

Jun. 30, 2013

Mar. 31, 2013

Dec. 31, 2014

Dec. 31, 2013

Dec. 31, 2012

Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]

Net actuarial gains (losses) of defined benefit plans

$ (63)

Prior service cost of defined benefit plans

Interest and debt expense

$ 95

$ 85

Provision for income taxes

1,053

592

176

Net income

$ (825)

$ (826)

$ (683)

$ (487)

$ (511)

$ (629)

$ (660)

$ (362)

(2,821)

(2,162)

$ (1,759)

Reclassification out of Accumulated Other Comprehensive Income [Member] | Accumulated Defined Benefit Plans Adjustment, Net Unamortized Gain (Loss) [Member]

Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]

Net actuarial gains (losses) of defined benefit plans

^[1],[2]

108

Provision for income taxes

(21)

(37)

Net income

Reclassification out of Accumulated Other Comprehensive Income [Member] | Accumulated Defined Benefit Plans Adjustment, Net Prior Service Cost (Credit) [Member]

Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]

Prior service cost of defined benefit plans

^[1],[2]

(5)

Provision for income taxes

Net income

(3)

Reclassification out of Accumulated Other Comprehensive Income [Member] | Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges [Member]

Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]

Interest and debt expense

Provision for income taxes

(1)

Net income

$ 1

[1]	Detailed in Note 11.
[2]	Pension expense is included in COR, R&D, SG&A and Restructuring charges/other in the Consolidated Statements of Income.

Quarterly financial data (unaudited) (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended								12 Months Ended
	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Quarterly Financial Information Disclosure [Abstract]
Revenue	$ 3,269	$ 3,501	$ 3,292	$ 2,983	$ 3,028	$ 3,244	$ 3,047	$ 2,885	$ 13,045	$ 12,205	$ 12,825
Gross profit	1,895	2,044	1,881	1,607	1,640	1,779	1,570	1,374	7,427	6,364	6,368
Acquisition charges	82	83	82	83	84	86	86	86	330	341	450
Restructuring charges/other	(27)	(9)	(4)	(11)	62	16	(282)	15	(51)	(189)	264
Operating profit	1,100	1,175	982	690	687	844	906	395	3,947	2,832	1,973
Net income	$ 825	$ 826	$ 683	$ 487	$ 511	$ 629	$ 660	$ 362	$ 2,821	$ 2,162	$ 1,759
Basic earnings per common share	$ 0.78	$ 0.77	$ 0.63	$ 0.44	$ 0.46	$ 0.56	$ 0.59	$ 0.32	$ 2.61	$ 1.94	$ 1.53
Diluted earnings per common share	$ 0.76	$ 0.76	$ 0.62	$ 0.44	$ 0.46	$ 0.56	$ 0.58	$ 0.32	$ 2.57	$ 1.91	$ 1.51

- Definition

The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.

+ References + Details

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References + Details